CN109642197A - system and method for thermal cycling - Google Patents
system and method for thermal cycling Download PDFInfo
- Publication number
- CN109642197A CN109642197A CN201680088726.2A CN201680088726A CN109642197A CN 109642197 A CN109642197 A CN 109642197A CN 201680088726 A CN201680088726 A CN 201680088726A CN 109642197 A CN109642197 A CN 109642197A
- Authority
- CN
- China
- Prior art keywords
- reaction
- heating element
- pedestal
- nucleic acid
- reaction vessel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 142
- 238000005382 thermal cycling Methods 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 206
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 196
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 196
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 133
- 230000003321 amplification Effects 0.000 claims abstract description 128
- 238000006243 chemical reaction Methods 0.000 claims description 427
- 238000010438 heat treatment Methods 0.000 claims description 184
- 239000012530 fluid Substances 0.000 claims description 150
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 claims description 136
- 239000011541 reaction mixture Substances 0.000 claims description 123
- 230000006854 communication Effects 0.000 claims description 69
- 238000004891 communication Methods 0.000 claims description 68
- 238000004519 manufacturing process Methods 0.000 claims description 63
- 238000001816 cooling Methods 0.000 claims description 59
- 230000003287 optical effect Effects 0.000 claims description 49
- 239000003153 chemical reaction reagent Substances 0.000 claims description 30
- 230000005284 excitation Effects 0.000 claims description 25
- 238000003752 polymerase chain reaction Methods 0.000 claims description 25
- 238000001514 detection method Methods 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 21
- 238000005070 sampling Methods 0.000 claims description 19
- 230000011664 signaling Effects 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- 230000004913 activation Effects 0.000 claims description 11
- 150000001768 cations Chemical class 0.000 claims description 11
- 238000007789 sealing Methods 0.000 claims description 11
- 238000005057 refrigeration Methods 0.000 claims description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 8
- 241000712079 Measles morbillivirus Species 0.000 claims description 6
- 241000709661 Enterovirus Species 0.000 claims description 5
- 241000607142 Salmonella Species 0.000 claims description 5
- 239000004411 aluminium Substances 0.000 claims description 5
- 229910052782 aluminium Inorganic materials 0.000 claims description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 230000006698 induction Effects 0.000 claims 3
- 230000008878 coupling Effects 0.000 claims 2
- 238000010168 coupling process Methods 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- 230000033228 biological regulation Effects 0.000 claims 1
- 238000009434 installation Methods 0.000 claims 1
- 230000002035 prolonged effect Effects 0.000 claims 1
- 239000000523 sample Substances 0.000 description 99
- 108020004414 DNA Proteins 0.000 description 44
- 229920002477 rna polymer Polymers 0.000 description 33
- 239000012472 biological sample Substances 0.000 description 29
- 239000003795 chemical substances by application Substances 0.000 description 27
- 230000004087 circulation Effects 0.000 description 22
- 230000015654 memory Effects 0.000 description 21
- 238000003860 storage Methods 0.000 description 21
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 239000000975 dye Substances 0.000 description 16
- 229940088598 enzyme Drugs 0.000 description 16
- 238000004925 denaturation Methods 0.000 description 15
- 230000036425 denaturation Effects 0.000 description 15
- 230000008859 change Effects 0.000 description 12
- -1 glucolase Proteins 0.000 description 12
- KDXKERNSBIXSRK-UHFFFAOYSA-N lysine Chemical compound NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 12
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 10
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 10
- 102100034343 Integrase Human genes 0.000 description 10
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 10
- 238000010367 cloning Methods 0.000 description 9
- 238000010839 reverse transcription Methods 0.000 description 9
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 8
- 241000700605 Viruses Species 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 241000725303 Human immunodeficiency virus Species 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 241001515965 unidentified phage Species 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000013500 data storage Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 4
- 229960005542 ethidium bromide Drugs 0.000 description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
- 239000000710 homodimer Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000701161 unidentified adenovirus Species 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 210000002845 virion Anatomy 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000835 electrochemical detection Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000007834 ligase chain reaction Methods 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 210000001138 tear Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- 108700012813 7-aminoactinomycin D Proteins 0.000 description 2
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 2
- 241000711549 Hepacivirus C Species 0.000 description 2
- 241000186781 Listeria Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000192086 Staphylococcus warneri Species 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- VGQOVCHZGQWAOI-UHFFFAOYSA-N UNPD55612 Natural products N1C(O)C2CC(C=CC(N)=O)=CN2C(=O)C2=CC=C(C)C(O)=C12 VGQOVCHZGQWAOI-UHFFFAOYSA-N 0.000 description 2
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 2
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000012445 acidic reagent Substances 0.000 description 2
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 108010004469 allophycocyanin Proteins 0.000 description 2
- VGQOVCHZGQWAOI-HYUHUPJXSA-N anthramycin Chemical compound N1[C@@H](O)[C@@H]2CC(\C=C\C(N)=O)=CN2C(=O)C2=CC=C(C)C(O)=C12 VGQOVCHZGQWAOI-HYUHUPJXSA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- CZPLANDPABRVHX-UHFFFAOYSA-N cascade blue Chemical compound C=1C2=CC=CC=C2C(NCC)=CC=1C(C=1C=CC(=CC=1)N(CC)CC)=C1C=CC(=[N+](CC)CC)C=C1 CZPLANDPABRVHX-UHFFFAOYSA-N 0.000 description 2
- TUESWZZJYCLFNL-DAFODLJHSA-N chembl1301 Chemical compound C1=CC(C(=N)N)=CC=C1\C=C\C1=CC=C(C(N)=N)C=C1O TUESWZZJYCLFNL-DAFODLJHSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- CTSPAMFJBXKSOY-UHFFFAOYSA-N ellipticine Chemical compound N1=CC=C2C(C)=C(NC=3C4=CC=CC=3)C4=C(C)C2=C1 CTSPAMFJBXKSOY-UHFFFAOYSA-N 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229950005911 hydroxystilbamidine Drugs 0.000 description 2
- 229910052738 indium Inorganic materials 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 210000000352 storage cell Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- QEQDLKUMPUDNPG-UHFFFAOYSA-N 2-(7-amino-4-methyl-2-oxochromen-3-yl)acetic acid Chemical compound C1=C(N)C=CC2=C1OC(=O)C(CC(O)=O)=C2C QEQDLKUMPUDNPG-UHFFFAOYSA-N 0.000 description 1
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- VIIIJFZJKFXOGG-UHFFFAOYSA-N 3-methylchromen-2-one Chemical compound C1=CC=C2OC(=O)C(C)=CC2=C1 VIIIJFZJKFXOGG-UHFFFAOYSA-N 0.000 description 1
- IHDBZCJYSHDCKF-UHFFFAOYSA-N 4,6-dichlorotriazine Chemical compound ClC1=CC(Cl)=NN=N1 IHDBZCJYSHDCKF-UHFFFAOYSA-N 0.000 description 1
- DBMJYWPMRSOUGB-UHFFFAOYSA-N 5-hexyl-6-phenylphenanthridin-5-ium-3,8-diamine;iodide Chemical compound [I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCCCCC)=C1C1=CC=CC=C1 DBMJYWPMRSOUGB-UHFFFAOYSA-N 0.000 description 1
- IHHSSHCBRVYGJX-UHFFFAOYSA-N 6-chloro-2-methoxyacridin-9-amine Chemical compound C1=C(Cl)C=CC2=C(N)C3=CC(OC)=CC=C3N=C21 IHHSSHCBRVYGJX-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- HRNOIAOFVVUYJU-UHFFFAOYSA-N 7-amino-3-methylchromen-2-one Chemical compound C1=C(N)C=C2OC(=O)C(C)=CC2=C1 HRNOIAOFVVUYJU-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 101150037123 APOE gene Proteins 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- TYBKADJAOBUHAD-UHFFFAOYSA-J BoBo-1 Chemical compound [I-].[I-].[I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC3=[N+](C4=CC=CC=C4S3)C)C=C2)C=C1 TYBKADJAOBUHAD-UHFFFAOYSA-J 0.000 description 1
- UIZZRDIAIPYKJZ-UHFFFAOYSA-J BoBo-3 Chemical compound [I-].[I-].[I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC=CC3=[N+](C4=CC=CC=C4S3)C)C=C2)C=C1 UIZZRDIAIPYKJZ-UHFFFAOYSA-J 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010050337 Cerumen impaction Diseases 0.000 description 1
- 238000007445 Chromatographic isolation Methods 0.000 description 1
- 102100023336 Chymotrypsin-like elastase family member 3B Human genes 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 101001023092 Condylactis gigantea Delta-actitoxin-Cps1a Proteins 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 108050009160 DNA polymerase 1 Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- 241000725619 Dengue virus Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000531123 GB virus C Species 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- ZIXGXMMUKPLXBB-UHFFFAOYSA-N Guatambuinine Natural products N1C2=CC=CC=C2C2=C1C(C)=C1C=CN=C(C)C1=C2 ZIXGXMMUKPLXBB-UHFFFAOYSA-N 0.000 description 1
- 241000724675 Hepatitis E virus Species 0.000 description 1
- 208000037262 Hepatitis delta Diseases 0.000 description 1
- 241000724709 Hepatitis delta virus Species 0.000 description 1
- 241000709721 Hepatovirus A Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001272567 Hominoidea Species 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 101900297506 Human immunodeficiency virus type 1 group M subtype B Reverse transcriptase/ribonuclease H Proteins 0.000 description 1
- 241000692870 Inachis io Species 0.000 description 1
- FGBAVQUHSKYMTC-UHFFFAOYSA-M LDS 751 dye Chemical compound [O-]Cl(=O)(=O)=O.C1=CC2=CC(N(C)C)=CC=C2[N+](CC)=C1C=CC=CC1=CC=C(N(C)C)C=C1 FGBAVQUHSKYMTC-UHFFFAOYSA-M 0.000 description 1
- 241001003141 Lactobacillus prophage Lj928 Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 206010027906 Monocytosis Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 1
- 102000014160 PTEN Phosphohydrolase Human genes 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 1
- 241000255964 Pieridae Species 0.000 description 1
- 241001040659 Plasmodium (Plasmodium) Species 0.000 description 1
- QBKMWMZYHZILHF-UHFFFAOYSA-L Po-Pro-1 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)C)C=C1 QBKMWMZYHZILHF-UHFFFAOYSA-L 0.000 description 1
- CZQJZBNARVNSLQ-UHFFFAOYSA-L Po-Pro-3 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)C)C=C1 CZQJZBNARVNSLQ-UHFFFAOYSA-L 0.000 description 1
- BOLJGYHEBJNGBV-UHFFFAOYSA-J PoPo-1 Chemical compound [I-].[I-].[I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC3=[N+](C4=CC=CC=C4O3)C)C=C2)C=C1 BOLJGYHEBJNGBV-UHFFFAOYSA-J 0.000 description 1
- GYPIAQJSRPTNTI-UHFFFAOYSA-J PoPo-3 Chemical compound [I-].[I-].[I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC=CC3=[N+](C4=CC=CC=C4O3)C)C=C2)C=C1 GYPIAQJSRPTNTI-UHFFFAOYSA-J 0.000 description 1
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 241000701550 Pseudoalteromonas virus PM2 Species 0.000 description 1
- 108010019653 Pwo polymerase Proteins 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- SUYXJDLXGFPMCQ-INIZCTEOSA-N SJ000287331 Natural products CC1=c2cnccc2=C(C)C2=Nc3ccccc3[C@H]12 SUYXJDLXGFPMCQ-INIZCTEOSA-N 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241001247837 Streptococcus phage B30 Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 108010001244 Tli polymerase Proteins 0.000 description 1
- DPXHITFUCHFTKR-UHFFFAOYSA-L To-Pro-1 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 DPXHITFUCHFTKR-UHFFFAOYSA-L 0.000 description 1
- QHNORJFCVHUPNH-UHFFFAOYSA-L To-Pro-3 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 QHNORJFCVHUPNH-UHFFFAOYSA-L 0.000 description 1
- MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 108010020713 Tth polymerase Proteins 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 201000006449 West Nile encephalitis Diseases 0.000 description 1
- 206010057293 West Nile viral infection Diseases 0.000 description 1
- ULHRKLSNHXXJLO-UHFFFAOYSA-L Yo-Pro-1 Chemical compound [I-].[I-].C1=CC=C2C(C=C3N(C4=CC=CC=C4O3)C)=CC=[N+](CCC[N+](C)(C)C)C2=C1 ULHRKLSNHXXJLO-UHFFFAOYSA-L 0.000 description 1
- ZVUUXEGAYWQURQ-UHFFFAOYSA-L Yo-Pro-3 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 ZVUUXEGAYWQURQ-UHFFFAOYSA-L 0.000 description 1
- GRRMZXFOOGQMFA-UHFFFAOYSA-J YoYo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2O1 GRRMZXFOOGQMFA-UHFFFAOYSA-J 0.000 description 1
- JSBNEYNPYQFYNM-UHFFFAOYSA-J YoYo-3 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=CC=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC(=[N+](C)C)CCCC(=[N+](C)C)CC[N+](C1=CC=CC=C11)=CC=C1C=CC=C1N(C)C2=CC=CC=C2O1 JSBNEYNPYQFYNM-UHFFFAOYSA-J 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- BGLGAKMTYHWWKW-UHFFFAOYSA-N acridine yellow Chemical compound [H+].[Cl-].CC1=C(N)C=C2N=C(C=C(C(C)=C3)N)C3=CC2=C1 BGLGAKMTYHWWKW-UHFFFAOYSA-N 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000013228 adenopathy Diseases 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 238000007845 assembly PCR Methods 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 108091092259 cell-free RNA Proteins 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000002939 cerumen Anatomy 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- ZYVSOIYQKUDENJ-WKSBCEQHSA-N chromomycin A3 Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 ZYVSOIYQKUDENJ-WKSBCEQHSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- VYXSBFYARXAAKO-UHFFFAOYSA-N ethyl 2-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]benzoate;hydron;chloride Chemical compound [Cl-].C1=2C=C(C)C(NCC)=CC=2OC2=CC(=[NH+]CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-UHFFFAOYSA-N 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 201000006747 infectious mononucleosis Diseases 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000007852 inverse PCR Methods 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 108010056929 lyticase Proteins 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 210000001006 meconium Anatomy 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 1
- VMCOQLKKSNQANE-UHFFFAOYSA-N n,n-dimethyl-4-[6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]aniline Chemical compound C1=CC(N(C)C)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 VMCOQLKKSNQANE-UHFFFAOYSA-N 0.000 description 1
- UPBAOYRENQEPJO-UHFFFAOYSA-N n-[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-4-formamido-1-methylpyrrole-2-carboxamide Chemical compound CN1C=C(NC=O)C=C1C(=O)NC1=CN(C)C(C(=O)NC2=CN(C)C(C(=O)NCCC(N)=N)=C2)=C1 UPBAOYRENQEPJO-UHFFFAOYSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229960003171 plicamycin Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 125000004424 polypyridyl Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229960000286 proflavine Drugs 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108010043524 protease E Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000000985 reactive dye Substances 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 108010042747 stallimycin Proteins 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- XJCQPMRCZSJDPA-UHFFFAOYSA-L trimethyl-[3-[4-[(e)-(3-methyl-1,3-benzothiazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]azanium;diiodide Chemical compound [I-].[I-].S1C2=CC=CC=C2N(C)\C1=C\C1=CC=[N+](CCC[N+](C)(C)C)C=C1 XJCQPMRCZSJDPA-UHFFFAOYSA-L 0.000 description 1
- DYMFZRARZACULM-UHFFFAOYSA-K trisodium;pyrene-1,3,6-trisulfonate Chemical compound [Na+].[Na+].[Na+].C1=C2C(S(=O)(=O)[O-])=CC=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 DYMFZRARZACULM-UHFFFAOYSA-K 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/36—Apparatus for enzymology or microbiology including condition or time responsive control, e.g. automatically controlled fermentors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5082—Test tubes per se
- B01L3/50825—Closing or opening means, corks, bungs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/36—Apparatus for enzymology or microbiology including condition or time responsive control, e.g. automatically controlled fermentors
- C12M1/38—Temperature-responsive control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/043—Hinged closures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/046—Function or devices integrated in the closure
- B01L2300/047—Additional chamber, reservoir
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1838—Means for temperature control using fluid heat transfer medium
- B01L2300/185—Means for temperature control using fluid heat transfer medium using a liquid as fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present disclosure provides nucleic acid amplification systems and methods of nucleic acid amplification using such systems.
Description
Background technique
Nucleic acid amplification method permission selectively expands and identifies interested core from complex mixture such as biological sample
Acid.Can be via amplification method known in the art, the method based on thermal cycle such as including polymerase chain reaction (PCR),
To expand interested nucleic acid.During or after expanding interested nucleic acid, amplified production can detecte, and by end user
Interpret testing result.Traditional nucleic acid amplification and detection method is usually directed to the heat circulating equipment for needing high-voltage power to input.It is real
When round pcr be related to using can real-time detection from experience nucleic acid amplification sample signal detector.Combined thermal cycle
A degree of power input is needed with detection, which limits the use of thermal cycler.
Point-of-care (POC) detection has under the conditions of laboratory infrastructure poor resource-constrained or real receiving
It tests the delay of room result and the potentiality from far-off regions for promoting infectious disease detection and disposition that follow-up may be more complex is carried out to patient.So
And nucleic acid amplification is carried out in POC setting and faces many challenges.For example, being inputted if necessary to high-voltage power to carry out in real time
PCR, then thermal cycler will have limited portability.For example, battery may exhaust quickly using such legacy system.
Similarly, can be used for being limited for the power supply of such system power supply, thus prevent in the case that varying environment and sufficiently
Use thermal cycler.
Summary of the invention
To the improved system and method for low-power thermal cycle, there are demands.Such low-power thermal cycle can make heat
Recycle unit is portable and operable in varied situations.For example, this kind of heat circulating equipment can be brought to scene or take to not
Easily obtain some areas of the country of normal power supplies.This disclosure provides be for quickly and easily carry out thermal cycle
System and method, to make to adapt to different point-of-care (POC) to be set to possibility.
The one aspect of present disclosure provides a kind of system for nucleic acid amplification, which includes pedestal, reaction
Container, shell, fluid flow components (or Fluid flow unit) and controller.
In some embodiments, the pedestal may include heating element (or heating unit).In some embodiments,
The occupied area of the pedestal may be less than or equal to about 5000mm2。
In some embodiments, the reaction vessel may include reaction chamber.In some embodiments, the reacting part
Part can be adjacent and in thermal communication with the heating element.In some embodiments, during use, the heating element
Thermal energy can be provided to the reaction mixture in the reaction chamber.In some embodiments, the reaction mixture may include core
Reagent necessary to sour sample and nucleic acid amplification.
In some embodiments, the shell can be releasably attached on the pedestal.In some embodiments
In, the shell can encapsulate the reaction vessel when being installed on the pedestal.In some embodiments, the shell
It may include at least one outlet, described in the excessively described reaction chamber of the source stream which allows convective fluid from the convective fluid reaches
At least one outlet.
In some embodiments, the fluid flow components can make the convective fluid from the source stream of the convective fluid
It crosses the reaction chamber and reaches at least one described outlet.
In some embodiments, the controller can be operably coupled to the heating element and the fluid stream
Dynamic component.In some embodiments, the controller can be programmed to that the reaction mixture is made to be subjected to one or more add
Hot and cold but recycles, to promote the nucleic acid amplification reaction to the reaction mixture.It in some embodiments, can be by (i)
The heating element is guided to provide thermal energy to the reaction chamber, and (ii) guides the fluid flow components so that the convection current
The excessively described reaction chamber of the source stream of body from the convective fluid reaches at least one described outlet, be subjected to the reaction mixture
One or more heating and cooling cycle, to promote the nucleic acid amplification reaction to the reaction mixture.
In some embodiments, the occupied area of the reaction chamber may be less than or equal to about 1000mm2。
In some embodiments, the occupied area may be less than or equal to about 500mm2。
In some embodiments, the occupied area may be less than or equal to about 300mm2。
In some embodiments, the occupied area of the pedestal may be less than or equal to about 2000mm2。
In some embodiments, the occupied area for the shell being installed on the pedestal may be less than or equal to about
5000mm2。
In some embodiments, the cross section of the reaction chamber is smaller than the cross section of the heating element.
In some embodiments, the ratio between the surface area of the reaction chamber and volume can be at least 100mm-1。
In some embodiments, the system can further comprise the power supply powered to the heating element.
In some embodiments, the power supply can power to the fluid flow components.
In some embodiments, the system can further comprise being operably connected in the pedestal or the shell
To the switch of the power supply.In some embodiments, the switch is adjustable from the power supply to the electricity of the heating element
Power supply.
In some embodiments, when the shell is installed on the pedestal, the switch is bootable from the electricity
Power supply of the source to the heating element.
In some embodiments, the shell may include room, which encapsulates described anti-when being installed on the pedestal
Answer container.
In some embodiments, the system can further comprise that the sample being installed on the heating element is supported
Device.In some embodiments, the sample holder can receive and fix the reaction vessel.
In some embodiments, when the reaction vessel is fixed on the sample holder, the reaction chamber can
It is adjacent and in thermal communication with the heating element.
In some embodiments, the pedestal can further include the excitation for being operably coupled to the reaction vessel
Energy source.In some embodiments, the excitation energy source can provide excitation energy to the reaction vessel, to induce instruction
The present or absent signal of the amplified production of the nucleic acid amplification reaction.
In some embodiments, the system can further comprise the first sensing with the reaction vessel sensing communication
Device.In some embodiments, the present or absent signal of the detectable instruction amplified production of the first sensor.
In some embodiments, the first sensor can be optical sensor, and the signal can be light
Learn signal.
In some embodiments, the system can further comprise the second sensing with the reaction vessel sensing communication
Device.In some embodiments, the second sensor can detect the reaction indoor one or more of the reaction vessel
Temperature at a position.
In some embodiments, the system can further comprise being operatively coupled in the pedestal or the shell
To the display of the first sensor.In some embodiments, the display can be configured to display and indicate the expansion
Increase production the present or absent signal of object.
In some embodiments, the system can further comprise being operatively coupled in the pedestal or the shell
To the first sensor and/or the display of the second sensor.In some embodiments, the display can be matched
1) display is set to indicate the present or absent signal of the amplified production and/or 2) show the described of the reaction vessel
React the temperature at indoor one or more of positions.
In some embodiments, the excitation energy source can be light source.
In some embodiments, the convective fluid can be convection gas.
In some embodiments, the convection gas can be air.
In some embodiments, the fluid flow components can be fan.
In some embodiments, the fluid flow components can be installed on the shell or the pedestal.
In some embodiments, the source of the convective fluid can be refrigeration unit.
In some embodiments, the heating element may include infrared heating unit.
In some embodiments, the heating element may include peltier (Peltier) heating unit.
In some embodiments, the heating element may include heating unit containing aluminium.
In some embodiments, the heating element may include electrical resistor heating element.
In some embodiments, the controller can be programmed to that the heating element is guided to provide to the reaction chamber
Thermal energy until the reaction mixture reaches the first temperature, and guides the fluid flow components so that the convective fluid
The reaction chamber is flowed through, until the reaction mixture reaches the second temperature lower than first temperature.
In some embodiments, the controller can be programmed to reach the second temperature when the reaction mixture
When guide the fluid flow components to reduce or terminate the flowing of the convective fluid.
In some embodiments, the controller may include in the susceptor.
In some embodiments, the reaction mixture may include one or more primers and polymerase.
In some embodiments, the reaction mixture may include buffer.
In some embodiments, the reaction mixture may include the active cation for adjusting the polymerase.
In some embodiments, the cation may include Mg2+Or Mn2+。
In some embodiments, one or more primers can have for HBV, HCV, FluA, FluB, CA16,
EV71, enterovirus, EBOV, EBV, measles virus, salmonella, HPV and/or the nucleic acid sequence of HIV selection.
In some embodiments, the nucleic acid amplification reaction can be polymerase chain reaction (PCR).
In some embodiments, the mean temperature of the convective fluid can be below about 15 DEG C.
In some embodiments, the mean temperature of the convective fluid can be below about 10 DEG C.
In some embodiments, the controller can be by using the thermal energy provided by the heating element to control
The rate of heat addition of reaction chamber is stated, and flows through the flowing of the reaction chamber using the convective fluid to control the reaction chamber
Cooling rate, to be heated and/or cooled to reaction mixture offer.
In some embodiments, when the rate of heat addition is greater than the cooling rate, the reaction mixture can be made
It is subjected to heating.
In some embodiments, when the rate of heat addition is less than the cooling rate, the reaction mixture can be made
It is subjected to cool to.
In some embodiments, the rate of heat addition can be at least 5 DEG C/s.
In some embodiments, the cooling rate can be at least 5 DEG C/s.
In some embodiments, in the case where the switch is not opened, the controller can not make described anti-
Mixture is answered to be subjected to one or more of heating and cooling cycle.
In some embodiments, after the switch is opened after postponing after a period of time, the controller can
The reaction mixture is set to be subjected to one or more of heating and cooling cycle.
In some embodiments, the reaction vessel can further include sampling unit.In some embodiments, institute
Stating sampling unit may include the sampler chamber being in fluid communication with the reaction chamber.
In some embodiments, the sampling unit can further include the collecting part for collecting nucleic acid samples.
In some embodiments, the sampling unit can further include the sealing for sealing the opening of the sampler chamber
Part.
In some embodiments, during use, the collecting part can pierce the seal member with by the core
Sour sample is discharged into the sampler chamber.
In some embodiments, the thickness of the side of the reaction chamber adjacent with the heating element is smaller than about
1mm。
The one aspect of present disclosure provides a kind of for nucleic acid amplification method comprising:
Activation system, the system include (i) pedestal, (ii) reaction vessel, (iii) shell and (iv) fluid flow components;And
The reaction mixture is set to be subjected to one or more heating and cooling cycle, to promote the nucleic acid to the reaction mixture
Amplified reaction.
In some embodiments, the pedestal may include heating element.In some embodiments, the pedestal accounts for
Ground area may be less than or equal to about 5000mm2。
In some embodiments, the reaction vessel may include reaction chamber.In some embodiments, the reacting part
Part can be adjacent and in thermal communication with the heating element.In some embodiments, the reaction chamber may include that reaction is mixed
Object is closed, which includes reagent necessary to nucleic acid samples and nucleic acid amplification.
In some embodiments, the shell can be releasably attached on the pedestal.In some embodiments
In, the shell can encapsulate the reaction vessel.In some embodiments, the shell may include at least one outlet, should
Outlet allows convective fluid to reach at least one described outlet from the excessively described reaction chamber of the source stream of the convective fluid.
In some embodiments, the fluid flow components can make the convective fluid from the source stream of the convective fluid
It crosses the reaction chamber and reaches at least one described outlet.
In some embodiments, the heating element can be guided to provide thermal energy, and (ii) to the reaction chamber by (i)
The fluid flow components are guided so that described in the excessively described reaction chamber arrival of the source stream of the convective fluid from the convective fluid
At least one outlet, to make the reaction mixture be subjected to one or more heating and cooling cycle, to promote to the reaction
The nucleic acid amplification reaction of mixture.
In some embodiments, the occupied area of the reaction chamber may be less than or equal to about 1000mm2。
In some embodiments, the occupied area of the pedestal may be less than or equal to about 2000mm2。
In some embodiments, may be mounted to the occupied area of the shell on the pedestal less than or equal to about
5000mm2。
In some embodiments, the cross section of the reaction chamber is smaller than the cross section of the heating element.
In some embodiments, the ratio between the surface area of the reaction chamber and volume can be at least 100mm-1。
In some embodiments, the activation in (a) can be carried out by being powered with power supply to the heating element.
In some embodiments, the power supply can power to the fluid flow components.
In some embodiments, the power supply can be operably coupled to by opening in the pedestal or the shell
Switch supply electric power.
In some embodiments, the switch can be opened by the way that the shell to be installed on the pedestal.
In some embodiments, the shell may include room, which encapsulates described anti-when being installed on the pedestal
Answer container.
In some embodiments, the method can further comprise that the reaction vessel is fixed to peace before (a)
It is attached on the sample holder on the heating element.
In some embodiments, when the reaction vessel is fixed on the sample holder, the reaction chamber can
It is adjacent and in thermal communication with the heating element.
In some embodiments, the method can further comprise providing excitation energy to the reaction vessel, to lure
Lead the present or absent signal for indicating the amplified production of the nucleic acid amplification reaction.
In some embodiments, the method can further comprise first provided with the reaction vessel sensing communication
Sensor, to detect the present or absent signal for indicating the amplified production.
In some embodiments, the first sensor can be optical sensor, and the signal can be light
Learn signal.
In some embodiments, the method can further comprise second provided with the reaction vessel sensing communication
Sensor, to detect the temperature of the indoor one or more positions of the reaction of the reaction vessel.
In some embodiments, the method can further comprise providing in the pedestal or the shell operationally
It is coupled to the display of first sensor and/or second sensor.In some embodiments, the display can be configured
Are as follows: (1) display indicates that the present or absent signal of the amplified production, and/or (2) show the described of the reaction vessel
React the temperature at indoor one or more of positions.
In some embodiments, the method can further comprise providing in the pedestal or the shell operationally
It is coupled to the display of first sensor.In some embodiments, the display can be configured to display and indicate the expansion
Increase production the present or absent signal of object.
In some embodiments, the excitation energy source can be light source.
In some embodiments, the convective fluid can be convection gas.
In some embodiments, the convection gas can be air.
In some embodiments, the fluid flow components can be fan.
In some embodiments, the fluid flow components can be installed on the shell or the pedestal.
In some embodiments, the source of the convective fluid can be refrigeration unit.
In some embodiments, the method can further comprise that will be equipped with the shell thereon before (a)
The pedestal is placed in refrigeration unit.
In some embodiments, the heating element may include infrared heating unit.
In some embodiments, the heating element may include peltier heating unit.
In some embodiments, the heating element may include heating unit containing aluminium.
In some embodiments, the heating element may include electrical resistor heating element.
In some embodiments, thermal energy can be provided to the reaction chamber, until the reaction mixture reaches the first temperature
Degree.In some embodiments, the convective fluid can be made to flow through the reaction chamber, be lower than until the reaction mixture reaches
The second temperature of first temperature.
In some embodiments, the method can further comprise when the reaction mixture reaches the second temperature
When reduce or terminate the flowing of the convective fluid.
In some embodiments, the reaction mixture may include one or more primers and polymerase.
In some embodiments, the reaction mixture may include buffer.
In some embodiments, the reaction mixture may include the active cation for adjusting the polymerase.
In some embodiments, the cation may include Mg2+Or Mn2+。
In some embodiments, one or more primers can have for HBV, HCV, FluA, FluB, CA16,
EV71, enterovirus, EBOV, EBV, measles virus, salmonella, HPV and/or the nucleic acid sequence of HIV selection.
In some embodiments, the nucleic acid amplification reaction can be polymerase chain reaction (PCR).
In some embodiments, the method can further comprise being controlled using the thermal energy provided by the heating element
The rate of heat addition of the reaction chamber is made, and flows through the flowing of the reaction chamber using the convective fluid to control the reaction
The cooling rate of room.
In some embodiments, the rate of heat addition can be greater than the cooling rate, to make the reaction mixture
It is subjected to heating.
In some embodiments, the rate of heat addition is smaller than the cooling rate, to make the reaction mixture
It is subjected to cool to.
In some embodiments, the rate of heat addition can be at least 5 DEG C/s.
In some embodiments, the cooling rate can be at least 5 DEG C/s.
In some embodiments, in (b), in the case where the switch is not opened, the reaction can not be made
Mixture is subjected to one or more of heating and cooling cycle.
In some embodiments, in (b), after the switch is opened after postponing after a period of time, can make
The reaction mixture is subjected to one or more of heating and cooling cycle.
In some embodiments, the method can further comprise deactivating the system after (b).
In some embodiments, the method can further comprise that the nucleic acid samples are placed on institute before (a)
It states in reaction vessel.
In some embodiments, the reaction vessel can further include sampling unit, and the sampling unit packet
Containing collecting part and the sampler chamber being in fluid communication with the reaction chamber.In some embodiments, can by on it or
The collecting part for wherein having collected the nucleic acid samples pierces through the seal member for sealing the opening of the sampler chamber, by the nucleic acid
Sample is placed in the reaction vessel.
The one aspect of present disclosure provides a kind of system for nucleic acid amplification, which includes pedestal, reaction
Container, shell and controller.
In some embodiments, the pedestal may include heating element.In some embodiments, the pedestal accounts for
Ground area may be less than or equal to about 5000mm2。
In some embodiments, the reaction vessel may include reaction chamber.In some embodiments, the reacting part
Part can be adjacent and in thermal communication with the heating element.In some embodiments, during use, the heating element
Thermal energy can be provided to the reaction mixture in the reaction chamber.In some embodiments, the reaction mixture may include core
Reagent necessary to sour sample and nucleic acid amplification.
In some embodiments, the shell can be releasably attached on the pedestal.In some embodiments
In, the shell can encapsulate the reaction vessel.In some embodiments, the shell may include cooling-part, the cooling
Component when the shell is installed on the pedestal with the reaction vessel thermal communication.
In some embodiments, the controller can be coupled to the heating element.In some embodiments, described
Controller can be programmed to that the reaction mixture is made to be subjected to one or more heating and cooling cycle, to promote to the reaction
The nucleic acid amplification reaction of mixture.In some embodiments, the reaction can be adjusted using the heating element by (i) to hold
The rate of heat addition of device, and (ii) adjust the cooling rate of the reaction vessel using the cooling-part, to keep the reaction mixed
It closes object and is subjected to one or more heating and cooling cycle, to promote the nucleic acid amplification reaction to the reaction mixture.
In some embodiments, the cooling-part can be that at least about material of 0.2J/g*K is formed by thermal capacity.
In some embodiments, the cooling-part can be that at least about material of 0.3J/g*K is formed by thermal capacity.
In some embodiments, the cooling-part can be that at least about material of 0.4J/g*K is formed by thermal capacity.
In some embodiments, the cooling-part can be that at least about material of 0.5J/g*K is formed by thermal capacity.
In some embodiments, the cooling-part can be that at least about material of 1.0J/g*K is formed by thermal capacity.
In some embodiments, the cooling-part is the solid comprising copper.
The one aspect of present disclosure provides one kind for nucleic acid amplification method, this method comprises:
Activation system, the system include (i) pedestal, (ii) reaction vessel and (iii) shell;And
The reaction mixture is set to be subjected to one or more heating and cooling cycle, to promote the nucleic acid to the reaction mixture
Amplified reaction.
In some embodiments, the pedestal may include heating element.In some embodiments, the pedestal accounts for
Ground area may be less than or equal to about 5000mm2。
In some embodiments, the reaction vessel may include reaction chamber.In some embodiments, the reacting part
Part can be adjacent and in thermal communication with the heating element.In some embodiments, the reaction chamber may include that reaction is mixed
Object is closed, which includes reagent necessary to nucleic acid samples and nucleic acid amplification.
In some embodiments, the shell can be releasably attached on the pedestal.In some embodiments
In, the shell can encapsulate the reaction vessel.In some embodiments, the shell may include cooling-part, the cooling
Component when the shell is installed on the pedestal with the reaction vessel thermal communication.
In some embodiments, the rate of heat addition of the reaction vessel can be adjusted using the heating element by (i),
(ii) adjusts the cooling rate of the reaction vessel using the cooling-part, come make the reaction mixture be subjected to one or
Multiple heating and cooling cycle, to promote the nucleic acid amplification reaction to the reaction mixture.
In some embodiments, the occupied area of the reaction chamber may be less than or equal to about 1000mm2。
In some embodiments, the occupied area of the pedestal may be less than or equal to about 2000mm2。
In some embodiments, the occupied area for the shell being installed on the pedestal may be less than or equal to about
5000mm2。
In some embodiments, the method can further comprise providing excitation energy to the reaction vessel, to lure
Lead the present or absent signal for indicating the amplified production of the nucleic acid amplification reaction.
In some embodiments, the method can further comprise first provided with the reaction vessel sensing communication
Sensor, to detect the present or absent signal for indicating the amplified production.
In some embodiments, the first sensor can be optical sensor, and the signal can be light
Learn signal.
In some embodiments, the method can further comprise second provided with the reaction vessel sensing communication
Sensor, to detect the temperature of the indoor one or more positions of the reaction of the reaction vessel.
In some embodiments, the method can further comprise providing in the pedestal or the shell operationally
It is coupled to the display of first sensor and/or second sensor.In some embodiments, the display is configured as:
(1) display indicates that the present or absent signal of the amplified production, and/or (2) show the described anti-of the reaction vessel
Answer the temperature at indoor one or more of positions.
In some embodiments, the method can further comprise providing in the pedestal or the shell operationally
It is coupled to the display of first sensor.In some embodiments, the display is configured as display and indicates the amplification
The present or absent signal of product.
According to the detailed description of the following illustrative embodiment that present disclosure only has shown and described, present disclosure
Other aspect and advantage will become obvious to those skilled in the art.It will recognize that present disclosure energy
Enough includes other and different embodiments, and its several details can be modified at multiple apparent aspects, is owned
These are all without departing from present disclosure.Correspondingly, attached drawing and description will be considered to be illustrative and not restrictive naturally.
It quotes and is incorporated to
The all publications, patents and patent applications referred in this specification are both incorporated herein by reference, and degree is such as
It is same particularly and individually to point out that each individual publication, patent or patent application are incorporated by reference into.
Detailed description of the invention
Novel feature of the invention is specifically explained in the appended claims.By reference to below to wherein utilize this hair
The detailed description and the accompanying drawings that the illustrative embodiment of bright principle is illustrated, it will obtain to the features and advantages of the present invention
It better understands, in the drawings:
Figure 1A and Figure 1B illustrates the example of the system of present disclosure.
Fig. 2 illustrates the example of the system of present disclosure.
Fig. 3 illustrates the internal structure of the system of present disclosure.
Fig. 4 illustrates the internal structure of the system of present disclosure.
It may include the display in the system of present disclosure that Fig. 5, which is illustrated,.
Fig. 6 illustrates the reaction vessel of present disclosure.
Fig. 7 shows the viewgraph of cross-section of the reaction vessel of present disclosure.
Fig. 8 shows the bottom view of the reaction vessel of present disclosure.
Fig. 9 shows the computer control system for being programmed or being otherwise configured to realize the method for present disclosure
System.
Specific embodiment
It is aobvious for those skilled in the art although the preferred embodiments of the invention have been illustrated and described herein
And be clear to, these embodiments only provide in an illustrative manner.Those skilled in the art are not departing from situation of the invention
Down now it will be appreciated that a variety of variations, change and replacement.It should be appreciated that the various substitutions of embodiment of the present invention described herein
Scheme can be used for implementing the present invention.
As used herein, term " sample " typically refers to containing or suspects any sample containing nucleic acid molecules.For example,
Samples subjects can be the biological sample containing one or more nucleic acid molecules.The biological sample can be from the body sample of subject
Product obtain (for example, extract or separation), the optional autoblood of the body sample (for example, whole blood), blood plasma, serum, urine, saliva,
Mucosal secretion, sputum, excrement and tear.The fluid or tissue sample that the body sample can be subject are (for example, skin-like
Product).In some instances, which is obtained from the cell-free body fluid of subject, such as whole blood.In this case, which can
Including Cell-free DNA and/or cell-free RNA.In some other examples, the sample be environmental sample (for example, soil, waste,
Surrounding air etc.), production piece (for example, sample from any industrial process) and foodstuff samples are (for example, dairy produce, plant
Product and meat products).
In some embodiments, sample directly is obtained without being further processed from subject.In some embodiments
In, in the pre-treatment sample of biological or chemical reaction (for example, nucleic acid amplification).For example, can be in addition biological sample and nucleic acid
Decomposition agent is added in sample holder before reagent necessary to expanding.The example of decomposition agent include Tris-HCl, EDTA,
Detergent (for example, Triton X-100, SDS), lysozyme, glucolase, protease E, viral endolysin, outer lysin, enzymatic hydrolysis
Enzyme, lyticase, Proteinase K, the endolysin from bacteriophage and outer lysin, come from withered grass at the endolysin from bacteriophage PM2
The endolysin of bacillus (B.subtilis) bacteriophage PBSX comes from lactobacillus prophage Lj928, Lj965, bacteriophage
The endolysin of 15Phiadh, the endolysin from streptococcus pneumonia bacteriophage Cp-I, Streptococcusagalactiae bacteriophage B30 it is difunctional
Peptide glycan lysin, the endolysin from prophage bacterium and outer lysin come from the interior of Listeria (Listeria) bacteriophage
Lysin, cave albumen-endolysin, 20 lysis genes of cell, holWMY Staphylococcus warneri (Staphylococcus wameri) M
Bacteriophage varphiWMY, the Iy5WMY of Staphylococcus warneri M bacteriophage varphiWMY, polysorbas20, PEG, KOH, NaCl and its
Combination.In some embodiments, decomposition agent is sodium hydroxide (NaOH).In some embodiments, biological sample is not spent
Dirty agent processing.
In some embodiments, sample is purified (for example, pure by filtering, centrifugation, column purification and/or magnetism
Change, for example, by using magnetic bead (for example, super-paramagnetic bead)) to obtain the nucleic acid purified.
Sample can have any suitable size or volume.In some instances, small size includes no more than about 5mL;No
More than about 4mL;No more than about 3mL;No more than about 2mL;No more than about 1mL;No more than about 500 μ L;No more than about 250 μ L;No
More than about 100 μ L;No more than about 90 μ L;No more than about 80 μ L;No more than about 70 μ L;No more than about 60 μ L;No more than about 50 μ L;
No more than about 40 μ L;No more than about 30 μ L;No more than about 25 μ L;No more than about 20 μ L;No more than about 15 μ L;No more than about 10 μ
L;No more than about 8 μ L;No more than about 6 μ L;No more than about 5 μ L;No more than about 4 μ L;No more than about 3 μ L;No more than about 2 μ L;No
More than about 1 μ L;No more than about 0.8 μ L;No more than about 0.5 μ L;No more than about 0.3 μ L;No more than about 0.2 μ L;No more than about 0.1
μL;No more than about 0.05 μ L;Or no more than about 0.01 μ L.
As used herein, term " body fluid " typically refers to any fluid that can be obtained from subject.Body fluid may include but
It is not limited to, for example, blood, urine, saliva, tear, sweat, body exudates, body excretions or being originated from subject or can be from
Any other fluid that subject obtains.Particularly, body fluid includes but is not limited to blood, serum, blood plasma, marrow, saliva, urine
Liquid, spinal fluid, tear, excrement, mucus, sweat, earwax, oil, glandular secretion object, celiolymph, sperm, vaginal secretion, comes gastric juice
Derived from the interstitial fluid of tumor tissues, ocular fluid, placental fluids, amniotic fluid, Cord blood, lymph, chamber liquid, sputum, fester, meconium, breast milk
And/or other secretion or excreta.
As used herein, term " nucleic acid " typically refers to the molecule comprising one or more nucleic acid subunits.Nucleic acid can
Including one or more selected from adenosine (A), cytimidine (C), guanine (G), thymidine (T) and uracil (U) or its variant
A subunit.Nucleotide may include A, C, G, T or U or its variant, which includes but is not limited to peptide nucleic acid (PNA).Nucleotide
It may include any subunit that can be mixed in the nucleic acid chains of growth.Such subunit can be A, C, G, T or U, or to one
A or multiple complementation A, C, G, T or U have specificity or with purine (that is, A or G or its variant) or pyrimidine (that is, C, T or U,
Or its variant) complementary any other subunit.Subunit can make each nucleic acid base or base group (for example, AA, TA, AT,
GC, CG, CT, TC, GT, TG, AC, CA or its uracil counterpart) it can be differentiated.In some instances, nucleic acid is deoxidation
Ribonucleic acid (DNA) or ribonucleic acid (RNA) or derivatives thereof.Nucleic acid can be single-stranded or double-strand.Nucleic acid may include one
Kind or the nucleotide of a variety of modifications, for example, methylated nucleotide and nucleotide analog.
As used herein, term " polymerase " typically refers to any enzyme for capableing of catalytic polymerization.The reality of polymerase
Example includes such as nucleic acid polymerase, transcriptase or ligase.Polymerase can be polymerase (polymerization enzyme)
Or polymerism enzyme (polymerizing enzyme).
As used herein, term " subject " typically refer to have can test or the entity of detectable hereditary information or
Medium.Subject can be people or individual.Subject can be vertebrate, such as mammal.The example of subject includes
Muroid, apes, the mankind, farm-animals, sport animals, pet, birds, dog, cat, horse, ox, sheep, pig, dolphin, rodent
(for example, mouse, rat) or insect.Other examples of subject include, for example, food, plant, soil and water.Subject can
To be living body or dead volume.The subject can be human or animal.
As used herein, term " about " or " close " typically refer to reasonably change, for example, specified amount +/- 10%,
+/- 9%, within +/- 8%, +/- 7%, +/- 6%, +/- 5%, +/- 4%, +/- 3%, +/- 2% or +/- 1%.
As used herein, term " reaction mixture " is typically referred to comprising for completing nucleic acid amplification (for example, DNA expands
Increase, RNA amplification) necessary to reagent composition, the non-limiting example of this kind of reagent includes having to target RNA or target DNA
The primer sets of specificity, the DNA generated by the reverse transcription of RNA, archaeal dna polymerase, reverse transcriptase are (for example, be used for the reverse of RNA
Record), suitable buffer (including zwitterionic buffer), co-factor (for example, divalent and monovalent cation), dNTP and other
Enzyme (for example, uracil-DNA glycosylase (UNG) etc.).In some cases, reaction mixture also may include one or more
Report agent.
As used herein, " report agent " typically refers to generate the composition of detectable signal, the presence of the signal or not
It whether there is in the presence of can be used for detecting amplified production.
As used herein, term " target nucleic acid " typically refers to have certain nucleosides in the starter population of nucleic acid molecules
The nucleic acid molecules of acid sequence, presence, amount and/or sequence or one of them or multinomial variation needs are measured.Target nucleus
Acid can be any kind of nucleic acid, including DNA, RNA and the like.As used herein, " target nucleus ribosomal ribonucleic acid (RNA) " is logical
Refer to the target nucleic acid as RNA.As used herein, " target DNA (DNA) " typically refers to the target nucleus as DNA
Acid.
In one aspect, this disclosure provides the systems for nucleic acid amplification.The system may include pedestal, the pedestal
It may include heating element, and the occupied area of the pedestal may be less than or equal to about 9000mm2.For example, the land occupation face of the pedestal
Product may be less than or equal to about 8000mm2, about 7000mm2, about 6000mm2, about 5000mm2, about 4500mm2, about 4000mm2, about
3500mm2, about 3000mm2, about 2500mm2, about 2000mm2, about 1500mm2, about 1000mm2, about 900mm2, about 800mm2, about
700mm2, about 600mm2, about 500mm2, about 400mm2, about 300mm2, about 200mm2, about 100mm2Deng.
The system can further comprise the reaction vessel comprising reaction chamber.The reaction chamber can it is adjacent with heating element and with
Thermal communication.During use, which can provide thermal energy to the reaction mixture in reaction chamber.The reaction mixture can
Include reagent necessary to nucleic acid samples and nucleic acid amplification.The occupied area of the reaction chamber may be less than or equal to about 2000mm2.Example
Such as, the occupied area of the reaction chamber may be less than or equal to about 1500mm2, about 1000mm2, about 900mm2, about 800mm2, about
700mm2, about 600mm2, about 500mm2, about 400mm2, about 300mm2, about 200mm2, about 100mm2Deng.In some embodiments
In, the cross section of reaction chamber is less than the cross section of heating element.
On the other hand, this disclosure provides the methods for nucleic acid amplification.This method may include activation system, should
System includes the pedestal that (i) includes heating element, and wherein the occupied area of the pedestal is less than or equal to about 5000mm2, (ii) packet
Reaction vessel containing reaction chamber, wherein the reaction chamber is adjacent and in thermal communication with heating element.The reaction chamber may include reaction
Mixture, the reaction mixture include reagent necessary to nucleic acid samples and nucleic acid amplification.The system can further comprise (iii)
The shell being releasably attached on pedestal.The shell can encapsulate reaction vessel, and the shell may include at least one outlet,
The outlet allows convective fluid to cross at least one described outlet of reaction chamber arrival from the source stream of convective fluid.The system may also include
(iv) so that convective fluid is crossed reaction chamber from the source stream of convective fluid and reach at least one fluid flow components exported.This method can
It further comprise that reaction mixture is made to be subjected to one or more heating and cooling cycle, to promote the nucleic acid to reaction mixture to expand
Increase reaction, this can guide heating element to provide thermal energy, and (ii) guidance fluid flow components so that convection current to reaction chamber by (i)
Fluid, which from the source stream of convective fluid crosses reaction chamber and reaches at least one outlet, to carry out.
In some embodiments, the occupied area of the pedestal may be less than or equal to about 9000mm2.For example, the pedestal
Occupied area may be less than or equal to about 8000mm2, about 7000mm2, about 6000mm2, about 5000mm2, about 4500mm2, about
4000mm2, about 3500mm2, about 3000mm2, about 2500mm2, about 2000mm2, about 1500mm2, about 1000mm2, about 900mm2, about
800mm2, about 700mm2, about 600mm2, about 500mm2, about 400mm2, about 300mm2, about 200mm2, about 100mm2Deng.
At any aspect of the multiple aspect, the shell and/or pedestal can have more than one outlet, for example, institute
2,3,4,5,6,7,8,9 or more outlets can be had by stating shell and/or pedestal, these outlets allow convective fluid from convection current
The source stream of fluid crosses reaction chamber and reaches at least one outlet.
The reaction vessel can be any container (for example, PCR pipe) that can receive the solution comprising nucleic acid samples.It should
Reaction vessel may include reaction chamber, and chemistry and/or biological respinse can occur in the reaction chamber.The reaction vessel can have
Different size, shape, weight and configurations.In some embodiments, which is round or oval tubulose.One
In a little embodiments, which is rectangle, square, diamond shape, circle, ellipse or triangle.The reaction vessel can be with
It is regular shape or irregular shape.For example, reaction vessel can be pipe, hole, capillary, cassette, cuvette, centrifuge tube or shifting
Liquid pipe tip.In some embodiments, the ratio between the surface area of the reaction vessel and volume are at least 100mm-1、200mm-1、
300mm-1、350mm-1、400mm-1、450mm-1、500mm-1Or it is bigger.The thickness of the side of the reaction chamber adjacent with heating element
It is smaller than about 3mm.For example, the thickness of the side of the reaction chamber adjacent with heating element be smaller than about 3mm, 2.5mm, 2.0mm,
1.5mm, 1.0mm, 0.9mm, 0.8mm, 0.7mm, 0.6mm, 0.5mm, 0.4mm, 0.3mm, 0.2mm, 0.1mm, 0.05mm etc..
The reaction vessel may include sampling unit.The sampling unit may include the sampler chamber being in fluid communication with reaction chamber.
The sampling unit may include the collecting part for collecting nucleic acid samples.In some embodiments, which includes that sealing is adopted
The seal member of the opening of specimen chamber.During use, which can pierce seal member and is adopted with being discharged into nucleic acid samples
In specimen chamber.
The seal member can be any conjunction for separating at least two volumes or separating volume and external environment
Suitable structure.Seal member can be synthesis film, such as by solid-state material (for example, semiconductor, metal, semimetal or nonmetallic)
Or the film that polymeric material (for example, polymer film) is formed.For example, seal member can be by sealing sampler chamber and by itself and external environment
Opaque, the transparent or semitransparent material separated is formed.In some embodiments, which is made of parafilm
Polymer film.
The system may include the shell being releasably attached on pedestal.The shell can the encapsulating when being installed on pedestal
Reaction vessel, and the shell may include at least one outlet, and which allows the source stream of convective fluid from convective fluid excessively anti-
Room is answered to reach at least one described outlet.In some embodiments, which comprises more than one outlet, for example, 2,3,4,
5,6,7 or more outlets.The occupied area of the shell may be less than or equal to about 9000mm2.For example, the land occupation face of the shell
Product may be less than or equal to about 8000mm2, about 7000mm2, about 6000mm2, about 5000mm2, about 4500mm2, about 4000mm2, about
3500mm2, about 3000mm2, about 2500mm2, about 2000mm2, about 1500mm2, about 1000mm2, about 900mm2, about 800mm2, about
700mm2, about 600mm2, about 500mm2, about 400mm2, about 300mm2, about 200mm2, about 100mm2Deng.The shell may include pacifying
The room of reaction vessel is encapsulated when being attached on pedestal.In some embodiments, the shell may include on being installed to pedestal up to
The room of small part encapsulating reaction vessel.
In addition, the system may include making convective fluid cross reaction chamber from the source stream of convective fluid to reach at least one outlet
Fluid flow components.The convective fluid can be convection gas, such as air or the mixture of one or more gases.The convection current
The source of fluid can be refrigeration unit, such as refrigerator.The fluid flow components can be fan.In some embodiments, by this
Fluid flow components are installed on shell or pedestal.
The system can further comprise the controller for being operably coupled to heating element and fluid flow components.The control
Device processed can be programmed to that reaction mixture is made to be subjected to one or more heating and cooling cycle, to promote the core to reaction mixture
Sour amplified reaction.This can guide heating element to provide thermal energy to reaction chamber for example, by (i), and (ii) guides fluid flow components
So that convective fluid from the source stream of convective fluid crosses reaction chamber and reaches at least one outlet and carries out.The controller may include in base
In seat.
The system can further comprise power supply.The power supply can be configured to heating element and/or fluid flow components
Power supply.The activation of the system can be realized by being powered with power supply to heating element and/or fluid flow components.
The system can include switch in pedestal and/or shell.The switch can be operably coupled to power supply, and
It is adjustable from power supply to heating element and/or the power supply of fluid flow components.For example, when shell is installed on pedestal,
The switch may be guided from power supply to heating element and/or the power supply of fluid flow components.It can be by opening pedestal or shell
In be operably coupled to the switch of power supply to supply electric power.The switch can be opened by the way that shell to be installed on pedestal.
The system may include sample holder.The sample holder can receive and fix reaction vessel.Work as reaction vessel
When fixed on sample holder, the reaction chamber in the reaction vessel can be adjacent and in thermal communication with heating element.Some
In embodiment, which is installed on heating element;This can ensure that reaction vessel or in which sample in fixation
When into sample holder or on sample holder with heating element thermal communication.
In the system of present disclosure, the pedestal can further include the excitation for being operably coupled to reaction vessel
Energy source.The excitation energy source can provide excitation energy to reaction vessel, to induce the amplified production of instruction nucleic acid amplification reaction
Present or absent signal.The excitation energy source can be light source or other inductive energy sources, such as light emitting diode, swash
Light device or other energy sources.The excitation energy source can be activated guiding excitation energy to comprising sample in the reaction chamber, from
And generate the generation of chemical or biological reactionss (for example, nucleic acid amplification reaction) and/or the transmitting signal (example of result on instruction sample
Such as, optical signalling, fluorescence signal and/or electrostatic signal).
The system may include one or more sensors, for example, 2,3,4,5,6,7 or more sensors.For example,
The system may include the first sensor with reaction vessel sensing communication.The presence of the detectable instruction amplified production of first sensor
Or the signal being not present.First sensor can be optical sensor, inductance sensor, electrochemical sensor, electrostatic transducer
And/or impedance transducer.The signal can be optical signalling, fluorescence signal and/or electrostatic signal.
The system can further comprise the second sensor with reaction vessel sensing communication.Second sensor is detectable anti-
Answer the temperature of the indoor one or more positions of reaction of container.
The system can further comprise that first sensor and/or the second sensing are operably coupled in pedestal or shell
One or more (for example, 1,2,3 or more) display of device.The display can be configured to display instruction amplified production
Present or absent signal and/or reaction vessel the indoor one or more positions of reaction temperature.
The heating element may include that infrared heating unit, peltier heating unit, heating unit containing aluminium and/or resistance add
Hot cell.
The controller can be programmed to guidance heating element and provide thermal energy to reaction chamber, until reaction mixture reaches the
One temperature, and fluid flow components are guided so that convective fluid flows through reaction chamber, until reaction mixture reaches lower than the first temperature
The second temperature of degree.The controller can be programmed to guide fluid flow components to subtract when reaction mixture reaches second temperature
Less or terminate convective fluid flowing.
First temperature can be about 80 DEG C to about 100 DEG C.For example, the first temperature can be about 87 DEG C to about 95 DEG C or about 90
DEG C to about 95 DEG C.First temperature can be about 92 DEG C to about 95 DEG C.First temperature can be greater than or equal to about 90 DEG C, 91 DEG C, 92
DEG C, 93 DEG C, 94 DEG C, 95 DEG C, 96 DEG C, 97 DEG C, 98 DEG C, 99 DEG C or 100 DEG C.Second temperature can be about 40 DEG C to about 70 DEG C or about
50 DEG C to about 60 DEG C.Second temperature can less than or equal to about 40 DEG C, 45 DEG C, 50 DEG C, 51 DEG C, 52 DEG C, 53 DEG C, 54 DEG C, 55 DEG C,
56 DEG C, 57 DEG C, 58 DEG C, 59 DEG C, 60 DEG C, 65 DEG C, 70 DEG C, 75 DEG C, 80 DEG C or 85 DEG C.
The reaction mixture may include one or more primers and polymerase.In some embodiments, reaction mixing
Object may include buffer.The reaction mixture may include the active cation for adjusting polymerase.The cation may include Mg2+
And/or Mn2+.One or more primers can have the sequence complementary with target nucleic acid sequence.
At any aspect of the multiple aspect, nucleic acid amplification reaction can be carried out using the primer sets for target nucleic acid.
Primer sets generally comprise one or more primers.For example, primer sets can include about 1,2,3,4,5,6,7,8,9,10,20,30,
40,50 kinds or more primers.In some embodiments, primer sets include to be directed to different amplified productions or different nucleic acid
The primer of amplified reaction.For example, primer sets may include the first primer and second primer complementary with nucleic acid chains product, the first primer
It is necessary to generating the first chain of the nucleic acid product complementary at least part of target nucleic acid, the second primer is generation and nucleic acid
Necessary to second chain of the nucleic acid product of at least part complementation of the first chain of product.
For example, primer sets can be directed to target RNA.The primer sets may include can be used for generate it is mutual at least part of target RNA
The first primer of the first chain of nucleic acid product of benefit.In the case where reverse transcription reaction, the first chain of nucleic acid product can be DNA.
The primer sets also may include that can be used for generating nucleic acid product second chain complementary at least part of the first chain of nucleic acid product
Second primer.In the case where the reverse transcription reaction carried out parallel with DNA cloning, the second chain of nucleic acid product be can be and oneself
One chain of nucleic acid (for example, DNA) product of the DNA chain complementation of RNA template generation.
If it is desired, any suitable number of primer sets can be used.It is, for example, possible to use about 1,2,3,4,5,6,7,8,
9,10 or more primer sets.When using multiple primer sets, one or more primer sets can respectively correspond to specific core
Sour amplified reaction or amplified production.
In some embodiments, using archaeal dna polymerase.Any suitable archaeal dna polymerase can be used, including commercially available
Archaeal dna polymerase.Archaeal dna polymerase typically refers to the enzyme that can be incorporated into nucleotide in such a way that template combines in DNA chain.
The non-limiting example of archaeal dna polymerase includes Taq polymerase, Tth polymerase, Tli polymerase, Pfu polymerase, VENT polymerization
Enzyme, DEEPVENT polymerase, EX-Taq polymerase, LA-Taq polymerase, Expand polymerase, Sso polymerase, Poc polymerase,
Pab polymerase, Mth polymerase, Pho polymerase, ES4 polymerase, Tru polymerase, Tac polymerase, Tne polymerase, Tma polymerization
Enzyme, Tih polymerase, Tfi polymerase, Platinum Taq polymerase, Hi-Fi polymerase, Tbr polymerase, Tfl polymerase,
Pfutubo polymerase, Pyrobest polymerase, Pwo polymerase, KOD polymerase, Bst polymerase, Sac polymerase, Klenow piece
Section and their variant, modified outcome and derivative.For certain thermal starting polymerase, it may be necessary at about 92 DEG C to 95
For about 2 minutes to the denaturing step of 10 minutes sections at a temperature of DEG C (for example, 94 DEG C to 95 DEG C), this is according to different poly-
Synthase may change heat distribution.
In some embodiments, using reverse transcriptase.Any suitable reverse transcriptase can be used.Reverse transcriptase is usually
Refer to the enzyme that nucleotide can be incorporated into DNA chain when in conjunction with RNA template.The non-limiting example of reverse transcriptase includes
HIV-1 reverse transcriptase, M-MLV reverse transcriptase, AMV reverse transcriptase, reverse transcriptase of telomere and their variant, modification
Product and derivative.
Target nucleic acid sequence can be related to disease.The disease can be related to virus such as RNA virus or DNA virus.In some realities
It applies in scheme, which can be selected from human immunodeficiency virus I (HIV I), human immunodeficiency virus II (HIV II), just gluing
Virus, Ebola virus, dengue virus, influenza virus, hepatitis virus, hepatitis A virus, hepatitis type B virus, hepatitis C
Virus, Hepatitis D virus, Hepatitis E virus, HGV RNA, Epstein-Barr virus, monocytosis,mononucleosis virus, giant cell
Virus, SARS virus, west nile fever virus, poliovirus, measles virus, herpes simplex virus, variola virus, adenopathy
Poison and varicella virus.In some embodiments, which is selected from H1N1 virus, H3N2 virus, H7N9 virus and H5N1
Virus.In some embodiments, which is 55 type adenovirus (ADV55) or 7 type adenovirus (ADV7).In some implementations
In scheme, which is to have the RNA- Hepatitis C Virus (RNA-HCV) of first.In some embodiments, the disease
Disease can be with pathogenic bacteria (for example, mycobacterium tuberculosis (Mycobacterium tuberculosis)) or pathogenic protozoa
(for example, plasmodium (Plasmodium)) is related.
In some embodiments, the disease is cancer.The non-limiting example of cancer includes colorectal cancer, bladder
Cancer, oophoroma, carcinoma of testis, breast cancer, cutaneum carcinoma, lung cancer, cancer of pancreas, gastric cancer, the cancer of the esophagus, the cancer of the brain, leukaemia, liver cancer, uterus
Endometrial carcinomas, prostate cancer and head and neck cancer.
In some embodiments, one or more primers have for HBV, HCV, FluA, FluB, CA16,
EV71, enterovirus, EBOV, EBV, measles virus, salmonella, HPV and/or the nucleic acid sequence of HIV selection.
Target nucleic acid that multiple nucleic acids amplified reaction can be used in amplification of nucleic acid sample simultaneously generates amplified production.In addition, nucleic acid
Amplification can be it is linear, exponential or combinations thereof.The non-limiting example of nucleic acid amplification method includes reverse transcription, primer
Extension, ligase chain reaction, relies on the amplification of unwindase (for example, after contacting nucleic acid with unwindase at polymerase chain reaction
Amplification), non-symmetric amplification, rolling circle amplification and multiple displacement amplification (MDA).In some embodiments, which can be with
It is DNA.In the case where expanding to target RNA, DNA can be obtained by the reverse transcription of RNA, and can be used then
DNA cloning generates the DNA product of amplification.The DNA product of amplification can indicate there is target RNA in the biological sample.To DNA
In the case where being expanded, using any DNA cloning method known in the art.The non-limiting example of DNA cloning method
Modification including polymerase chain reaction (PCR), PCR is (for example, PCR, ApoE gene, assembly PCR, asymmetric in real time
PCR, digital pcr, emulsion-based PCR, transfer to PCR (dial-out PCR), rely on the PCR of unwindase, nest-type PRC, heat start PCR,
Inverse PCR, methylation status of PTEN promoter, micro- primer PCR, multiplex PCR, nest-type PRC, overlapping-extension PCR, hot asymmetric interlaced
PCR, fall progressively PCR) and ligase chain reaction (LCR).In some embodiments, DNA cloning is linear.In some implementations
In scheme, DNA cloning is exponential.In some embodiments, DNA cloning is realized using nest-type PRC, this can improve inspection
Survey the sensitivity of the DNA product of amplification.
At any aspect of the multiple aspect, nucleic acid amplification reaction as described herein can carry out in parallel.In general, parallel
Amplified reaction is the amplified reaction occurred in same reaction chamber simultaneously.Parallel nucleic acid amplification reaction can carry out as follows: example
It such as, in the reaction chamber include and keeping this anti-for reagent necessary to each nucleic acid amplification reaction to obtain reaction mixture
Mixture is answered to be subjected to for condition necessary to each nucleic acid amplification reaction.For example, reverse transcription amplification and DNA cloning can be put down as follows
It carries out capablely: is provided in the reaction chamber for reagent necessary to both amplification methods to obtain reaction mixture, and make this
Reaction mixture is subjected to being adapted for the condition of the two amplified reactions.By RNA reverse transcription generate DNA can in parallel into
Row is expanded to generate the DNA product of amplification.Any suitable number of nucleic acid amplification reaction can be carried out in parallel.In some implementations
In scheme, carry out at least 1 in parallel, 2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,30,
40,50,100,200,300,400,500,1000,10000 or more nucleic acid amplification reactions.
The mean temperature of the convective fluid can be below about 25 DEG C.For example, the mean temperature of the convective fluid can be below about
24℃、23℃、22℃、21℃、20℃、19℃、18℃、17℃、16℃、15℃、14℃、13℃、12℃、11℃、10℃、9
℃、8℃、7℃、6℃、5℃、4℃、3℃、2℃、1℃、0℃。
The controller can control the rate of heat addition of reaction chamber by using the thermal energy provided by heating element, and make
Flow through the flowing of reaction chamber with convective fluid to control the cooling rate of reaction chamber, thus to reaction mixture provide heating and/
Or it is cooling.When the rate of heat addition is greater than cooling rate, reaction mixture can be made to be subjected to heating.When the rate of heat addition is less than cooling rate
When, reaction mixture can be made to be subjected to cool to.The rate of heat addition can be at least 0.1 DEG C/s.For example, the rate of heat addition can be at least 0.5 DEG C/
s、1℃/s、2℃/s、3℃/s、4℃/s、5℃/s、6℃/s、7℃/s、8℃/s、9℃/s、10℃/s、11℃/s、12℃/s、
13 DEG C/s, 14 DEG C/s, 15 DEG C/s, 16 DEG C/s, 17 DEG C/s, 18 DEG C/s, 19 DEG C/s, 20 DEG C/s, 21 DEG C/s etc..Cooling velocity can be
At least 0.1 DEG C/s.For example, cooling rate can be at least 0.5 DEG C/s, 1 DEG C/s, 2 DEG C/s, 3 DEG C/s, 4 DEG C/s, 5 DEG C/s, 6 DEG C/s,
7℃/s、8℃/s、9℃/s、10℃/s、11℃/s、12℃/s、13℃/s、14℃/s、15℃/s、16℃/s、17℃/s、18
DEG C/s, 19 DEG C/s, 20 DEG C/s, 21 DEG C/s etc..
In some embodiments, in the case where switch is not opened, the controller passes through reaction mixture
By one or more heating and cooling cycle.For example, the controller only can be such that reaction mixture is subjected to when switch is opened
It is heated or cooled.In some embodiments, after switch is opened after postponing after a period of time, which makes to react
Mixture is subjected to one or more heating and cooling cycle.
In some embodiments, before activation system, the method can further comprise being fixed to reaction vessel
It is installed on the sample holder of heating element.When reaction vessel is fixed on sample holder, the reaction of the reaction vessel
It room can be adjacent and in thermal communication with heating element.In some embodiments, sample holder is installed on heating element;
This can ensure that reaction vessel or in which sample be fixed to sample holder in or sample holder on when with heating element heat
Connection.
The method of present disclosure can further comprise providing excitation energy to reaction vessel, to induce instruction nucleic acid amplification
The present or absent signal of the amplified production of reaction.Excitation energy can be by light source or other inductive energy sources, such as shine
Diode, laser or other energy sources provide.Excitation energy can be guided to comprising sample in the reaction chamber, to generate
Indicate that the generation of chemical or biological reactionss (for example, nucleic acid amplification reaction) and/or the transmitting signal of result are (for example, light on sample
Learn signal, fluorescence signal and/or electrostatic signal).
In the method for present disclosure, it is possible to provide one or more sensors are (for example, 2,3,4,5,6,7 or more
A sensor).For example, this method may include the first sensor provided with reaction vessel sensing communication, with detection instruction amplification
The present or absent signal of product.First sensor can be optical sensor, inductance sensor, electrochemical sensor,
Electrostatic transducer and/or impedance transducer.The signal can be optical signalling, fluorescence signal and/or electrostatic signal.
In some embodiments, the method includes providing the second sensor with reaction vessel sensing communication, with inspection
Survey the temperature of the indoor one or more positions of reaction of reaction vessel.The reaction chamber of second sensor detectable response container
The temperature of interior one or more positions.
The method may include providing in pedestal or shell to be operably coupled to first sensor and/or second sensor
One or more (for example, 1,2,3 or more) display.The display can be configured to display instruction amplified production
The temperature of the indoor one or more positions of the reaction of present or absent signal and/or reaction vessel.
Before activation system, the pedestal for being equipped with shell thereon can be placed on to refrigeration unit (for example, refrigerator, refrigeration
Room etc.) in.
In the method for present disclosure, thermal energy can be provided to reaction chamber, until reaction mixture reaches the first temperature, and
And convective fluid can be made to flow through reaction chamber, until reaction mixture reaches the second temperature lower than the first temperature.This method can be into
One step includes reducing or terminating the flowing of convective fluid when reaction mixture reaches second temperature.
The reaction vessel may include sampling unit;The sampling unit may include collecting part and be in fluid communication with reaction chamber
Sampler chamber.It can be by piercing through the opening of sealing sampler chamber with the collecting part for having collected nucleic acid samples on or in which
Seal member places nucleic acid samples in the reaction vessel.
On the other hand, this disclosure provides the systems for nucleic acid amplification.The system may include comprising heating part
The pedestal of part, and the occupied area of the pedestal may be less than or equal to about 9000mm2.For example, the occupied area of the pedestal can be small
In or equal to about 8000mm2, about 7000mm2, about 6000mm2, about 5000mm2, about 4500mm2, about 4000mm2, about 3500mm2、
About 3000mm2, about 2500mm2, about 2000mm2, about 1500mm2, about 1000mm2, about 900mm2, about 800mm2, about 700mm2, about
600mm2, about 500mm2, about 400mm2, about 300mm2, about 200mm2, about 100mm2Deng.
The system may include the reaction vessel comprising reaction chamber.The reaction chamber can be adjacent with heating element and heat connects therewith
It is logical.During use, heating element can provide thermal energy to the reaction mixture in reaction chamber;The reaction mixture may include nucleic acid
Reagent necessary to sample and nucleic acid amplification.The occupied area of the reaction chamber may be less than or equal to about 2000mm2.For example, this is anti-
The occupied area of room is answered to may be less than or equal to about 1500mm2, about 1000mm2, about 900mm2, about 800mm2, about 700mm2, about
600mm2, about 500mm2, about 400mm2, about 300mm2, about 200mm2, about 100mm2Deng.In some embodiments, reaction chamber
Cross section is less than the cross section of heating element.In some embodiments, the occupied area of reaction chamber is less than accounting for for heating element
Ground area.
The system may include the shell being releasably attached on pedestal.The shell can be when being installed on pedestal at least
Reaction vessel is partially or even wholly encapsulated, and the shell may include cooling-part, which is installed to base in shell
When on seat with reaction vessel thermal communication.
The system may include the controller for being operably coupled to heating element.The controller can be programmed to make to react
Mixture is subjected to one or more heating and cooling cycle, to promote the nucleic acid amplification reaction to reaction mixture.This can pass through
(i) the cooling speed of reaction vessel is adjusted using cooling-part using the rate of heat addition of heating element adjusting reaction vessel and (ii)
Rate carries out.
On the other hand, this disclosure provides the methods for nucleic acid amplification.This method may include activation system, should
System includes the pedestal that (i) includes heating element, and the occupied area of the pedestal may be less than or equal to about 5000mm2, (ii) includes
The reaction vessel of reaction chamber, the reaction chamber can be adjacent and in thermal communication with heating element, and the reaction chamber may include reaction
Mixture, the reaction mixture include reagent necessary to nucleic acid samples and nucleic acid amplification, and (iii) is releasably attached to
Shell on pedestal, which can encapsulate reaction vessel, and the shell may include cooling-part, and the cooling-part is in the shell
When being installed on pedestal with reaction vessel thermal communication.This method can further comprise that reaction mixture is made to be subjected to one or more add
Hot and cold but recycles, and to promote the nucleic acid amplification reaction to reaction mixture, this can adjust reaction using heating element by (i)
The rate of heat addition of container and (ii) are realized using the cooling rate of cooling-part adjusting reaction vessel.In some embodiments
In, the occupied area of the pedestal is less than or equal to about 9000mm2、8000mm2, about 7000mm2, about 6000mm2, about 5000mm2, about
4500mm2, about 4000mm2, about 3500mm2, about 3000mm2, about 2500mm2, about 2000mm2, about 1500mm2, about 1000mm2, about
900mm2, about 800mm2, about 700mm2, about 600mm2, about 500mm2, about 400mm2, about 300mm2, about 200mm2, about 100mm2
Deng.
The cooling-part can be at least about 0.1J/g*K, for example, at least about 0.2J/g*K, at least about 0.3J/ by thermal capacity
G*K, at least about 0.4J/g*K, at least about 0.5J/g*K, at least about 1.0J/g*K, at least about 1.5J/g*K, at least about 2.0J/g*
K, at least about 2.5J/g*K or bigger material are formed.In some embodiments, which is the solid comprising copper.
The nucleic acid samples can be biological sample, the biological sample such as obtained from subject.In the presence of for from subject
Obtain a variety of methods of biological sample.It include: directly into cyclic system from the non-limiting example that subject obtains biological sample
System (for example, via syringe or other needles are intravenous or intra-arterial entrance) collects the biological sample of secretion (for example, excrement, urine
Liquid, sputum, saliva etc.), surgical operation (for example, biopsy), wiping (for example, cheek swab, oropharynx swab), liquid relief and breathing.This
Outside, biological sample can be obtained from any region of anatomy of subject locating for desired biological sample.
The biological sample directly obtained from subject can usually refer in addition to collecting biological sample from subject for into one
It walks except processing, the biological sample not being further processed after being obtained from subject.For example, can by following steps directly from
Subject obtains blood: into the circulatory system of subject, taking out blood (for example, passing through needle) from subject, and make to take out
Blood enter in storage.The storage may include reagent (for example, anti-coagulants), so that blood sample can be used for further dividing
Analysis.In another example, swab can be used to obtain the epithelial cell on the oralpharyngeal surfaces of subject.Biology is being obtained from subject
After sample, the swab containing biological sample can be made to contact with fluid (for example, buffer), to collect biology stream from the swab
Body.Alternatively, can be pre-processed before biological sample is supplied to system to it.
In some embodiments, when providing biological sample in the reaction vessel, the biological sample is not yet purified.One
In a little embodiments, when biological sample is supplied to reaction vessel, the nucleic acid of the biological sample is not yet extracted.It will for example, working as
It, can not be from the RNA or DNA extracted in biological sample in the biological sample when biological sample is supplied to reaction vessel.In addition,
In some embodiments, before biological sample is supplied to reaction vessel, it can not be concentrated and be present in the biological sample
Target nucleic acid (for example, target RNA or target DNA).Alternatively, the dilution or dense of the sample can be carried out before sample is supplied to system
Contracting.
The reaction mixture also may include the reagent of the target nucleic acid of detection amplification.The reagent, which can be, can generate and can examine
The report agent of signal is surveyed, the existence or non-existence instruction amplified production of the detectable signal whether there is.Detectable signal it is strong
Degree can be proportional to the amount of amplified production.For example, detectable signal can with the amount of amplified production directly linearly, index ratio
Example, inverse proportion, or the proportionate relationship with any other type.In some cases, when amplified production with initial by expanding
The different types of nucleic acid of target nucleic acid it is generated when, the intensity of detectable signal is proportional to the amount of the target nucleic acid initially expanded.
For example, in the case where the DNA obtained by parallel reverse transcription and amplification from reverse transcription is to expand target RNA, for the two
Reagent necessary to reacting may also include the report agent that can produce detectable signal, and the DNA of detectable signal instruction amplification is produced
The presence of object and/or the target RNA of amplification.The intensity of detectable signal can be with the DNA product of amplification and/or the initial target of amplification
The amount of RNA is proportional.Using for report agent also makes it possible real-time amplification method, including for the real-time of DNA cloning
PCR。
Report agent can be connected by covalently or non-covalently key with the nucleic acid including amplified production.Non-covalent bond it is non-
Limitative examples include ionic interaction, Van der Waals force, hydrophobic interaction, hydrogen bonding and combinations thereof.In some implementations
In scheme, report agent reports that the variation of agent level can be used for detecting amplified production in conjunction with initial reactant.In some realities
It applies in scheme, report agent is only detectable (or undetectable) when nucleic acid amplification carries out.In some embodiments, light
Reactive dye (for example, fluorescent dye) is learned with agent of giving a report.Reagent for detecting the target nucleic acid of amplification can be nucleic acid and combine
Dyestuff.The dyestuff can be DNA intercalative dye.The non-limiting example of dyestuff includes Eva green, and SYBR is green, and SYBR is blue, DAPI,
Propidium iodide (propidium iodine), Hoeste, SYBR gold, ethidium bromide, acridine, proflavin, acridine orange, acridine yellow,
Fluorescent coumarin (fluorcoumanin), ellipticine, daunomycin, chloroquine, distamycin D, chromomycin, Homidium Bromide
(homidium), mithramycin, more pyridine rutheniums (ruthenium polypyridyl), Anthramycin (anthramycin) are luxuriant and rich with fragrance
Pyridine and acridine, ethidium bromide, propidium iodide, the own ingot of iodate (hexidium iodide), dihydro second ingot, second ingot homodimer-
1 and second ingot homodimer -2, single Azide second ingot (ethidium monoazide) and ACMA, Hoechst33258,
Hoechst 33342, Hoechst 34580, DAPI, acridine orange, 7-AAD, actinomycin D, LDS751, hydroxystilbamidine
(hydroxystilbamidine), SYTOX is blue, and SYTOX is green, SYTOX orange, POPO-1, POPO-3, YOYO-1, YOYO-3,
TOTO-1, TOTO-3, JOJO-1, LOLO-1, BOBO-1, BOBO-3, PO-PRO-1, PO-PRO-3, BO-PRO-1, BO-PRO-
3, TO-PRO-1, TO-PRO-3, TO-PRO-5, JO-PRO-1, LO-PRO-1, YO-PRO-1, YO-PRO-3, PicoGreen,
OliGreen, RiboGreen, SYBR gold, SYBR green I, SYBR green II, SYBR DX, SYTO-40, -41, -42, -43, -44, -
45 (indigo plants), SYTO-13, -16, -24, -21, -23, -12, -11, -20, -22, -15, -14, -25 (green), SYTO-81, -80, -
82, -83, -84, -85 (orange), SYTO-64, -17, -59, -61, -62, -60, -63 (red), fluorescein, fluorescein isothiocynate
(FITC), tetramethylrhodamine isothiocyanates (TRITC), rhodamine, tetramethylrhodamine, R-PE, Cy-2, Cy-
3, Cy-3.5, Cy-5, Cy5.5, Cy-7, texas Red (Texas Red), Phar-Red, allophycocyanin (APC), Sybr
Green I, Sybr green II, Sybr gold, CellTracker is green, 7-AAD, second ingot homodimer I, second ingot homodimer II, second ingot
Homodimer III, ethidium bromide, umbelliferone, eosin, green fluorescent protein, erythrosine, cumarin, methylcoumarin, pyrene,
Peacock green, Stilbene, fluorescein, cascade blue (cascade blue), dichlorotriazine amine fluorescein, dansyl Cl, fluorescence lanthanide series metal
Complex compound (such as those include the complex compound of europium and terbium), carboxyl tetrachlorofluorescein, 5 and/or 6- Fluoresceincarboxylic acid (FAM), 5- (or
6-) iodacetyl amido fluorescein, 5- { [2 (and 3) -5- (acetyl group sulfydryl)-succinyl group] amino } fluorescein (SAMSA- fluorescence
Element), Sulforhodamine B sulfonic acid chloride, 5- and/or 6- carboxyrhodamine (ROX), 7- amino-methyl-cumarin, 7- amino -4-
Methylcoumarin -3- acetic acid (AMCA), BODIPY fluorogen, 8- methoxyl group pyrene -1,3,6- trisulfonic acid trisodium salt, 3,6- bis- sulphurs
Acid -4- amino-naphthalimide, phycobniliprotein, AlexaFluor 350,405,430,488,532,546,555,568,
594,610,633,635,647,660,680,700,750 and 790 dyestuff, DyLight 350,405,488,550,594,633,
650,680,755 and 800 dyestuffs or other fluorogens.
In some embodiments, report agent is sequence specific oligonucleotide probes, can be miscellaneous with amplified production
There is optical activity when friendship.Since probe is in conjunction with the sequence-specific of amplified production, the use of oligonucleotide probe be can be improved
The specificity and sensitivity of detection.Probe can be connected to any optical activity report agent (for example, dyestuff) as described herein, and
It may also include the optically active quencher that can block associated dyestuff.The non-limiting reality of the probe for agent of giving a report can be used
Example includes TaqMan probe, TaqMan Tamara probe, TaqMan MGB probe or Lion probe.
Report agent can be RNA oligonucleotide probe, may include the optical activity dyestuff (example being adjacently located on probe
Such as, fluorescent dye) and quencher.Dyestuff and quencher in close proximity to can blocked dye optical activity.Probe can with wait expand
The target sequence of increasing combines.Once the exonuclease activity of archaeal dna polymerase is broken probe during amplification, then quencher and dye
Material separation, and free dyestuff regains its optical activity, which can then be detected.
Report agent can be molecular beacon (molecular beacon).Molecular beacon may include, for example, in hairpin conformation
Oligonucleotides one end on the quencher that connects.It is optical activity dyestuff in the other end of the oligonucleotides, for example, fluorescence contaminates
Material.In hairpin structure, optical activity dyestuff and quencher are tightly enough approached, and enable the light of quencher blocked dye
Learn activity.However, once hybridize with amplified production, the oligonucleotides, that is, linear conformation and with the target sequence on the amplified production
Hybridization.The linearisation of oligonucleotides leads to the separation of optical activity dyestuff and quencher, so that optical activity is restored, and
It can be detected.Molecular beacon can improve the specific and sensitive of detection to the sequence-specific of the target sequence on amplified production
Degree.
In some embodiments, report agent is radioactive species.The non-limiting example of radioactive species includes14C、123I、124I、125I、131I、Tc99m、35S or3H。
In some embodiments, report agent is the enzyme that can generate detectable signal.Detectable signal can pass through enzyme pair
Its substrate, or the activity of specific substrates is generated in the case where enzyme has multiple substrates.It can be non-with the enzyme for agent of giving a report
Limitative examples include alkaline phosphatase, horseradish peroxidase, I2- galactosidase, alkaline phosphatase, beta galactose glycosides
Enzyme, acetylcholinesterase and luciferase.
Reagent necessary to reaction vessel nucleic acid expands can be provided to nucleic acid samples.In some embodiments, it tries
Agent includes one or more of: (i) reverse transcriptase, (ii) archaeal dna polymerase and (iii) drawing for target nucleic acid (for example, RNA)
Object group.It includes reverse transcriptase (for example, Sensiscript and Omniscript turns that some examples of reagent, which may include commercially available,
Record enzyme), the premix of archaeal dna polymerase (for example, HotStarTaq archaeal dna polymerase) and dNTPs is (for example, Qiagen One-
Step RT-PCR or One-Step RT-qPCR kit).
In some embodiments, sample is provided in sample container such as reaction vessel.It can be provided in reaction vessel
Any component of sample, including target nucleic acid, the reagent of the target nucleic acid of detection amplification and/or for the reagent of nucleic acid amplification, to obtain
Obtain reaction mixture.Any suitable reaction vessel can be used.In some embodiments, reaction vessel includes main body, the master
Body may include inner surface, outer surface, open end and opposite closed end.In some embodiments, reaction vessel includes cap.It should
Cap can be configured in its end in contact main body that is open, so that closing the open end of reaction vessel when being contacted.Some
In the case of, the cap and reaction vessel are permanently connected, so that it remains attached to reaction vessel in the case where opening and closing configuration.One
In a little situations, which is dismountable, so that cap is separated with reaction vessel when reaction vessel is opened.In some embodiments
In, reaction vessel can be sealed, it is optionally gas-tight seal.The reaction vessel can be close (fluid-tight) of liquid.
Reaction vessel may include main body and cap;The cap can be removably attached in main body or permanently connected with main body.
The main body may include the one or more walls to form reaction chamber and sampler chamber, and sampler chamber can be in fluid communication with reaction chamber.Some
In embodiment, reaction chamber and sampler chamber are spatially at least partially separated from each other.For example, between reaction chamber and sampler chamber
There may be sealings, at least partly prevent fluid from flowing between reaction chamber and sampler chamber.In some embodiments, instead
Answer the sealing between room and sampler chamber that can be pierced (for example, puncture) to form opening, so that fluid can be flowed to from reaction chamber
Sampler chamber, or vice versa.Sampler chamber may include opening, and seal member can be located at opening or the inside of sampler chamber, from
And indoor content (for example, reaction mixture) and outdoor environment are separated.The cap may include being configured as obtaining simultaneously
Retain the collecting part (for example, needle or recess) of sample.The size of collecting part and the opening of sampler chamber configure in the following manner:
When opening cap closure, collecting part can be adapted in the opening, pierce through seal member and by be retained thereon or in which sample
Product are discharged into sampling room (for example, be discharged into reaction mixture or include in other solution in sampler chamber).
Any size can be provided for reaction vessel.The reaction vessel, which can be configured to have, contains no more than about 100 μ L
Reaction mixture volume.For example, the reaction vessel can be configured to have containing no more than about 0.01 μ L, 0.03 μ L,
0.05μL、0.07μL、0.1μL、0.5μL、1μL、2μL、3μL、4μL、5μL、6μL、7μL、8μL、9μL、10μL、15μL、20μL、
25 μ L, 30 μ L, 35 μ L, 40 μ L, 45 μ L, 50 μ L, 55 μ L, 60 μ L, 65 μ L, 70 μ L, 80 μ L, 90 μ L, 100 μ L, 150 μ L or 200 μ
The volume of L reaction mixture.The reaction vessel can have be configured as containing be no more than fall into any two value described herein it
Between in the range of volume volume.
The height of reaction vessel may be less than or equal to about 0.1mm, 0.2mm, 0.3mm, 0.4mm, 0.5mm, 1mm, 1.5mm,
2mm、2.5mm、3mm、4mm、5mm、6mm、7mm、8mm、9mm、10mm、15mm、20mm、25mm、30mm、35mm、40mm、
50mm, 60mm or 70mm.The height of reaction vessel can be fallen between any two value as described herein.
The cross-sectional area of reaction vessel can be at least about 1mm2、5mm2、10mm2、20mm2、30mm2、40mm2、50mm2、
60mm2、70mm2、80mm2、90mm2、100mm2、150mm2、200mm2、250mm2、300mm2、350mm2、400mm2、450mm2、
500mm2、550mm2、600mm2、650mm2、700mm2、750mm2、800mm2、850mm2、900mm2、950mm2、1000mm2、
1100mm2、1200mm2、1300mm2、1400mm2Or 1500mm2.The cross-sectional area of reaction vessel can fall into as described herein any
Between two values.
The thickness of the wall of reaction vessel can no more than about 0.01mm, about 0.05mm, about 0.1mm, about 0.15mm, about 0.2mm,
About 0.25mm, about 0.3mm, about 0.35mm, about 0.4mm, about 0.5mm, about 0.6mm, about 0.7mm, about 0.8mm, about 0.9mm, about
1.0mm, about 2.0mm, about 3.0mm, about 4.0mm, about 5.0mm, about 6.0mm, about 7.0mm, about 8.0mm, about 9.0mm, about 10mm,
About 15mm, about 20mm etc..
Reaction vessel can be made of any suitable material, and the non-limiting example of such material includes glass, metal, modeling
Material and combinations thereof.Reaction vessel can by allow optical signalling in reaction vessel leave reaction vessel optical clear or
Trnaslucent materials is made.Reaction vessel can be left the material of the optical signalling of reaction vessel and be made by may filter that or do not filter.?
In some embodiments, reaction vessel is by allowing the transparent material inside detector observing response container to be formed.In some realities
It applies in scheme, the inside of reaction vessel can be imaged.Alternatively, can detect and measure the optical signalling for leaving reaction vessel
Amount.
Sample holder can receive reaction vessel.Reaction vessel can be removably supplied to sample holder.
Reaction vessel can be inserted into sample holder or take out it from sample holder.Reaction vessel can be placed on the disclosure
It is removed from support component in the support component of the system of content or by it.
It may be through after a period of time when nucleic acid amplification reaction occurs.The system may include can be anti-in nucleic acid amplification
The detector of signal is detected during should occurring.The detector can be able to detect signal without removing sample from system.
At any aspect of the multiple aspect, detector can detect amplified production (for example, the DNA product of amplification, amplification
RNA product).Any suitable detection method known in the art can be used in the detection of amplified production (DNA including amplification)
To realize.The concrete type of used detection method may depend on, for example, specific amplified production, the reaction for amplification
Whether the type of container, other reagents in reaction mixture, report agent include in the reactive mixture, and using reporting
The concrete type of used report agent when agent.The non-limiting example of detection method includes optical detection, spectral detection, electrostatic
Detection, Electrochemical Detection etc..Optical detecting method includes but is not limited to fluorimetry and UV-Visible absorption.Spectrum inspection
Survey method includes but is not limited to mass spectrography, nuclear magnetic resonance (NMR) spectral method and infra-red sepectrometry.Electrostatic detection methods include but not
It is limited to the technology based on gel, for example, gel electrophoresis.Electrochemical detection method includes but is not limited to the efficient liquid in amplified production
To the Electrochemical Detection of amplified production after phase chromatographic isolation.
The detector can be able to detect the optical signalling from sample.The optical signalling can be from the glimmering of sample
Light or other luminous signals.Optical signalling can be generated in the stimulation light for being supplied to the sample by sample response.Stimulate light can
It is provided by light source.The light source can be in system.In some embodiments, light is absorbed by the sample, and electromagnetic radiation light.Hair
The light penetrated can be in identical or different wavelength with the light of absorption.In some embodiments, optical signalling is from light source
Light reflection.Alternatively, light can be irradiated across sample, and detector can be able to detect the light across sample.
It in some embodiments, will be about the presence of amplified production (for example, DNA product of amplification) and/or the letter of amount
Breath output is to recipient.The information about amplified production can be exported there are many method.It, can be real when nucleic acid amplification is carrying out
When such information is provided.In other cases, once nucleic acid amplification is completed, so that it may provide the information.In some embodiment party
In case, some data can be provided in real time, and once expand completion, so that it may other data be presented.
In some embodiments, this type of information is visually (for example, over the display) or oral (for example, by medical treatment
Practitioner) it is supplied to recipient.In some embodiments, this type of information provides in report.Report may include any number
Desired element, the non-limiting example of the element includes about subject (for example, gender, age, race, healthy shape
Condition etc.) initial data, processed data (for example, graphical display (for example, figure, chart, tables of data, data summarization), determine
Cycle threshold, target polynucleotide initial amount calculated value) information, about whether there are the conclusion of target nucleic acid, diagnostic message,
Prognosis information, disease information, etc., and combinations thereof.The report (for example, hard copy) that this report can be used as printing provides, or
Electronic report offer is provided.In some embodiments (including the case where wherein providing electronic report), this type of information via
Such as monitor or television, the screen operationally being connect with the unit for obtaining amplified production, tablet computer screen, mobile system
The electronic consoles output such as system screen.The report of printing and electronic report can be stored respectively in file or database, so that it
Can be accessed for being compared with later report.
Any suitable communication media (including for example, network connection, wireless connection, cloud or internet connection) can be used
Report is sent to the recipient of Local or Remote position.In some embodiments, the system for report being sent to recipient,
Such as personal computer, phone, plate or other systems.This report can check online, be stored in the system of recipient or beat
It prints off and.In the presence of other suitable methods for transmitting report, the non-limiting example of this method includes mailing hard copy report
It accuses so that reception and/or recipient are checked.
The information for including in report or report can be exported to various types of recipient.The non-limit of such recipient
Property example processed includes therefrom obtaining the subject, doctor, the doctor for treating subject, the clinic for clinical test of biological sample
Monitor, nurse, researcher, Laboratory Technician, the representative of drugmaker, health care companies, biotech company, doctor
Institute, human assistance's tissue, health care management person, electronic system (for example, one of medical records of storage such as subject or
Multiple stage computers and/or one or more computer server), Public Health Practice person, other medical workers and other medical treatment
Facility.
Shell can partially or even wholly surround the component (for example, reaction vessel) of the system.Shell can laterally and/
Or the component (for example, reaction vessel) of the system is surrounded in top and bottom.Shell can be flexible or rigid structure.Detection
Device may include in shell.In some embodiments, detector is located at the outside of the shell of the system.Detector, which can be, is
The component part of system.Alternatively, detector can be dismountable or can separate with system.
Optical path can be provided between sample and detector.Signal from sample can reach detector via the optical path.Come
It may pass through optical path from the optical signalling of sample and reach detector.The optical path may include the direct sight between sample and detector.
In some embodiments, one or more optical elements can be provided between sample and detector.The example of optical element can
Optics member including lens, reflecting mirror, prism, diffusing globe, condenser, optical filter, dichroscope, optical fiber or any other type
Part.
Optical path can be disposed entirely in the shell of system.Optically optical path can be isolated with ambient enviroment for the shell.Example
Such as, which can be lighttight, so that the interference optics that may interfere with optical path can be provided seldom in shell or not provided
Signal.Light from hull outside may cannot be introduced into enclosure interior.The optics detected by detector can be advantageously reduced in this
The inaccuracy of signal.
Optical path can be retained while nucleic acid amplification occurs.When nucleic acid amplification occurs via optical path, detector can be with
The signal from sample can constantly or periodically be detected.
In some embodiments, use battery pack as the power supply to system power supply.The battery pack can be used for heating
Component, fluid flow components and/or detector power supply.
The power supply can provide low-voltage for the system of present disclosure.In some embodiments, which is less than
Or be equal to about 60V, 50V, 48V, 40V, 30V, 24V, 20V, 18V, 16V, 15V, 14V, 13V, 12V, 11V, 10V, 9V, 8V, 7V,
6V, 5V, 4V, 3V, 2V or 1V.In some embodiments, using less than or equal to about 50V, 40V, 30V, 24V, 20V, 18V,
The low-voltage of 16V, 15V, 14V, 13V, 12V, 11V, 10V, 9V, 8V, 7V, 6V, 5V, 4V, 3V, 2V or 1V to heating element, stream
Body mobile parts, excitation energy source and/or detector power supply.
In some embodiments, the method that low-power can be used for operating system or execute present disclosure.For example, can make
With about 84W come operating system or the method for executing present disclosure.In some embodiments, low-power less than or equal to about
250W、200W、150W、130W、120W、110W、100W、90W、85W、84W、83W、80W、75W、70W、65W、60W、55W、
50W, 45W, 40W, 35W, 30W, 25W, 20W, 15W, 10W, 5W, 1W, 500mW, 100mW, 50mW, 10mW, 5mW or 1mW.For
The amount of the power of operating system or execution method can be fallen between any two value as described herein.
In many aspects, amplified production is generated using primer extension reaction.Primer extension reaction is typically included in
Reaction mixture was incubated into for the first duration and under the second temperature lower than the first temperature by reaction mixture at a temperature of one
Incubate the circulation of the second duration.First temperature can be denaturation temperature.First duration can be the denaturation duration.
Second temperature can be elongating temperature.Second duration, which can be, extends the duration.
Denaturation temperature can according to the specific nucleic acid sample for example analyzed, in nucleic acid samples target nucleic acid particular source (example
Such as, virion, bacterium), used reagent and/or desired reaction condition and change.For example, denaturation temperature can be about
80 DEG C to about 110 DEG C.In some instances, denaturation temperature can be about 90 DEG C to about 100 DEG C.In some instances, denaturation temperature
It can be about 90 DEG C to about 97 DEG C.In some instances, denaturation temperature can be about 92 DEG C to about 95 DEG C.In other other examples
In, denaturation temperature can be at least or be equal to about 80 DEG C, 81 DEG C, 82 DEG C, 83 DEG C, 84 DEG C, 85 DEG C, 86 DEG C, 87 DEG C, 88 DEG C, 89 DEG C,
90 DEG C, 91 DEG C, 92 DEG C, 93 DEG C, 94 DEG C, 95 DEG C, 96 DEG C, 97 DEG C, 98 DEG C, 99 DEG C or 100 DEG C.
The denaturation duration can according to the specific nucleic acid sample for example analyzed, in nucleic acid samples target nucleic acid particular source
(for example, virion, bacterium), used reagent and/or desired reaction condition and change.For example, when denaturation continues
Between can less equal than about 300 seconds, 240 seconds, 180 seconds, 120 seconds, 90 seconds, 60 seconds, 55 seconds, 50 seconds, 45 seconds, 40 seconds, 35 seconds,
30 seconds, 25 seconds, 20 seconds, 15 seconds, 10 seconds, 5 seconds, 2 seconds or 1 second.For example, denaturation the duration can be no more than 120 seconds, 90 seconds,
60 seconds, 55 seconds, 50 seconds, 45 seconds, 40 seconds, 35 seconds, 30 seconds, 25 seconds, 20 seconds, 15 seconds, 10 seconds, 5 seconds, 2 seconds or 1 second.
Elongating temperature can according to the specific nucleic acid sample for example analyzed, in nucleic acid samples target nucleic acid particular source (example
Such as, virion, bacterium), used reagent and/or desired reaction condition and change.For example, elongating temperature can be about
30 DEG C to about 80 DEG C.In some instances, elongating temperature can be about 35 DEG C to about 72 DEG C.In some instances, elongating temperature can
It is about 45 DEG C to about 65 DEG C.In some instances, elongating temperature can be about 35 DEG C to about 65 DEG C.In some instances, extend temperature
Degree can be about 40 DEG C to about 60 DEG C.In some instances, elongating temperature can be about 50 DEG C to about 60 DEG C.In other other examples
In, elongating temperature can be to be no more than or be equal to about 35 DEG C, 36 DEG C, 37 DEG C, 38 DEG C, 39 DEG C, 40 DEG C, 41 DEG C, 42 DEG C, 43 DEG C, 44
℃、45℃、46℃、47℃、48℃、49℃、50℃、51℃、52℃、53℃、54℃、55℃、56℃、57℃、58℃、59
℃、60℃、61℃、62℃、63℃、64℃、65℃、66℃、67℃、68℃、69℃、70℃、71℃、72℃、73℃、74
DEG C, 75 DEG C, 76 DEG C, 77 DEG C, 78 DEG C, 79 DEG C or 80 DEG C.
Extend the duration can according to the specific nucleic acid sample for example analyzed, in nucleic acid samples target nucleic acid particular source
(for example, virion, bacterium), used reagent and/or the desired reaction condition needed and change.Continue for example, extending
Time can be less equal than about 300 seconds, 240 seconds, 180 seconds, 120 seconds, 90 seconds, 60 seconds, 55 seconds, 50 seconds, 45 seconds, 40 seconds, 35
Second, 30 seconds, 25 seconds, 20 seconds, 15 seconds, 10 seconds, 5 seconds, 2 seconds or 1 second.For example, 120 seconds, 90 can be no more than by extending the duration
Second, 60 seconds, 55 seconds, 50 seconds, 45 seconds, 40 seconds, 35 seconds, 30 seconds, 25 seconds, 20 seconds, 15 seconds, 10 seconds, 5 seconds, 2 seconds or 1 second.
At any aspect of the multiple aspect, the primer extension reaction of multiple circulations can be carried out.It is any appropriate to carry out
The circulation of number.For example, the recurring number carried out can be followed with less than about 100,90,80,70,60,50,40,30,20,10 or 5
Ring.The recurring number of progress may depend on, for example, obtaining detectable amplified production (for example, there are targets in nucleic acid samples for instruction
The DNA amplification product of the detectable amount of RNA) necessary to recurring number (for example, cycle threshold (Ct)).For example, can detect
Amplified production (for example, instruction there are the DNA products of the detectable amount of target RNA in nucleic acid samples) necessary to recurring number can
It is followed with less equal than about 100 circulations, 75 circulations, 70 circulations, 65 circulations, 60 circulations, 55 circulations, 50
Ring, 40 circulations, 35 circulations, 30 circulations, 25 circulations, 20 circulations, 15 circulations, 10 circulations or 5 circulations.This
Outside, in some embodiments, it is being less than about 100,75,70,65,60,55,50,45,40,35,30,25,20,15,10 or 5
Cycle threshold (Ct) under obtain the amplifiable product of detectable amount (there are the detectable of target RNA for example, in instruction biological sample
The DNA product of amount)
Amplification generate instruction exist expanded target nucleic acid detectable amount amplified production needed for the time can according to from
The particular cycle of the middle nucleic acid samples for obtaining target nucleic acid, the specific nucleic acid amplified reaction and desired amplified reaction that will carry out
It counts and changes.For example, the amplification of target nucleic acid can be 120 minutes or shorter, 90 minutes or shorter, 60 minutes or shorter, 50 minutes
Or shorter, 45 minutes or shorter, 40 minutes or shorter, 35 minutes or shorter, 30 minutes or shorter, 25 minutes or shorter, 20 points
Clock or it is shorter, 15 minutes or shorter, periods of 10 minutes or shorter or 5 minutes or shorter generate instruction there are target nucleic acid can
The amplified production of detection limit.
In some embodiments, the amplification of target RNA is at 120 minutes or shorter, 90 minutes or shorter, 60 minutes or more
It is short, 50 minutes or shorter, 45 minutes or shorter, 40 minutes or shorter, 35 minutes or shorter, 30 minutes or shorter, 25 minutes or
It is shorter, 20 minutes or shorter, 15 minutes or shorter, periods of 10 minutes or shorter or 5 minutes or shorter generates instruction and exists
The DNA amplification product of the detectable amount of target RNA.
In some embodiments, reaction mixture can be made to undergo the primer extension reaction of multiple series.The multiple system
Single series in column may include the specific primer extension of multiple circulations, which is characterized in that, for example, as herein its
Condition is specifically denaturalized and extended described in his place.In general, for example, for Denaturing and/or extension condition, Mei Gedan
A series is different from other single series of at least one of the multiple series.For example, when continuing with regard to denaturation temperature, denaturation
Between, elongating temperature and extend in the duration any one, two, three or all for four, single series can be different
Another single series in the multiple series.In addition, multiple series may include any number of single series, for example,
At least about or about 2,3,4,5,6,7,8,9,10 or more single serial.
For example, the primer extension reaction of multiple series may include First Series and second series.First Series, for example, can
Including more than ten recycle primer extension reaction, wherein each circulation of First Series include (i) by reaction mixture about
It incubates and is no more than 30 seconds at 92 DEG C to about 95 DEG C, subsequent (ii) incubates the reaction mixture at about 35 DEG C to about 65 DEG C not to be surpassed
Spend about one minute.Second series, such as, it may include the primer extension reaction recycled more than ten, wherein each of second series
Circulation includes that (i) incubated reaction mixture no more than 30 seconds at about 92 DEG C to about 95 DEG C, and subsequent (ii) mixes the reaction
Object incubates no more than about 1 minute at about 40 DEG C to about 60 DEG C.In this specific example, first and second series they
It is different in elongating temperature condition.However, the example is not intended to limit, because times of different extensions and Denaturing can be used
Meaning combination.
In some embodiments, gradual time the time spent in (that is, system from temperature transition to an another temperature)
And/or ramp rate can be vital factor in amplification.For example, amplification generates instruction, there are the detectable amounts of target nucleic acid
Amplified production needed for temperature and time can be changed according to ramp rate and/or gradual time.Ramp rate can influence to use
In the temperature and time of amplification.
Gradual time and/or ramp rate can be different between cycles.However in some embodiments, it recycles
Between gradual time and/or ramp rate be identical.Gradual time and/or ramp rate can be based on the samples handled
It is adjusted.
In some embodiments, such as according to the property of sample and reaction condition it determines gradual between different temperatures
Time.Accurate temperature and incubative time can also be determined according to the property of sample and reaction condition.In some embodiments,
Single sample is handled into (for example, being subjected to amplification condition) repeatedly using multiple thermal cycles, each thermal cycle is for example gradual
It is different on time, temperature and/or incubative time.It then can the best or optimal thermal cycle for specific sample selection.This is provided
For tested specific sample or the steady and efficient method of sample combination discretion thermal cycle.
In some embodiments, target nucleic acid is subjected to Denaturing before primer extension reaction starting.In multiple series
Primer extension reaction in the case where, target nucleic acid can be subjected to Denaturing before executing the multiple series, or can be in institute
It states and is subjected to Denaturing between multiple series.For example, target nucleic acid can be between the First Series and second series in multiple series
It is subjected to Denaturing.The non-limiting example of such Denaturing includes denaturation temperature distribution (for example, one or more denaturation temperature
Degree) and denaturant.
In some embodiments, nucleic acid samples are preheated before carrying out primer extension reaction.Preheat the temperature of nucleic acid samples
It spends (for example, preheating temperature) and the duration (for example, pre- thermal endurance) can be according to the specific nucleic acid samples for example analyzed
And change.In some instances, by nucleic acid samples preheat no more than about 60 minutes, 50 minutes, 40 minutes, 30 minutes, 25 minutes,
20 minutes, 15 minutes, 10 minutes, 9 minutes, 8 minutes, 7 minutes, 6 minutes, 5 minutes, 4 minutes, 3 minutes, 2 minutes, 1 minute, 45
Second, 30 seconds, 20 seconds, 15 seconds, 10 seconds or 5 seconds.In some instances, by nucleic acid samples about 80 DEG C to about 110 DEG C at a temperature of
Preheating.In some instances, by nucleic acid samples about 90 DEG C to about 100 DEG C at a temperature of preheat.In some instances, by nucleic acid
Sample about 90 DEG C to about 97 DEG C at a temperature of preheat.In some instances, the temperature by nucleic acid samples at about 92 DEG C to about 95 DEG C
The lower preheating of degree.In some instances, nucleic acid samples are being no more than or are being equal to about 80 DEG C, 81 DEG C, 82 DEG C, 83 DEG C, 84 DEG C, 85
DEG C, 86 DEG C, 87 DEG C, 88 DEG C, 89 DEG C, 90 DEG C, 91 DEG C, 92 DEG C, 93 DEG C, 94 DEG C, 95 DEG C, 96 DEG C, 97 DEG C, 98 DEG C, 99 DEG C or 100
It is preheated at a temperature of DEG C.
The time needed for any aspect of the multiple aspect, the element of Method Of Accomplishment can be according to the specific step of this method
Suddenly change.For example, the time quantum of the element of Method Of Accomplishment can be about 5 minutes to about 120 minutes.In other instances, it completes
The time quantum of the element of method can be about 5 minutes to about 60 minutes.In other instances, the time quantum of the element of Method Of Accomplishment can
It is about 5 minutes to about 30 minutes.In other instances, the time quantum of the element of Method Of Accomplishment can shorter than or be equal to 120 minutes, it is short
In or equal to 90 minutes, shorter than or equal to 75 minutes, shorter than or equal to 60 minutes, shorter than or equal to 45 minutes, shorter than or be equal to
40 minutes, shorter than or be equal to 35 minutes, shorter than or be equal to 30 minutes, shorter than or be equal to 25 minutes, shorter than or be equal to 20 minutes, it is short
In or be equal to 15 minutes, shorter than or be equal to 10 minutes or shorter than or be equal to 5 minutes.
The system can accurately control the temperature of sample to obtain desired temperature curve.The system can incite somebody to action
Temperature control about ± 5 DEG C, ± 4 DEG C, ± 3 DEG C, ± 2 DEG C, ± 1.2 DEG C, ± 1 DEG C, ± 0.7 DEG C, ± 0.5 DEG C, ± 0.3 DEG C, ±
In 0.1 DEG C, ± 0.05 DEG C, ± 0.01 DEG C, ± 0.005 DEG C or ± 0.001 DEG C.The system can be advantageously able in low-voltage
And/or the temperature control of high quality is provided when operating under low-power.The system can provide while with small size
The temperature of high quality controls.
The signal for detecting the sample from experience amplification can carry out in the whole process.The detection can be in amplification procedure
It is carried out continuously or is carried out in one or more points.Sample can emit optical signalling in the whole process.The optical signalling can be with
The amount of the target nucleic acid expanded in sample is related.
It can be with real-time display data related with the signal detected.For example, can be shown while expanding with
The process of nucleic acid amplification and/or the related data of the result of nucleic acid amplification.In some embodiments, one or more displays
It can be built in system.For example, display may be provided on the shell and/or pedestal of system/in.Any description of display
It is applicable to any kind of output module.Display may include the audio or tactile output of visual displays and information.It is aobvious
Show that device can show information on screen or other kinds of user interface (UI).For example, screen can be built in system.
In some embodiments, data are shown in individually display equipment.The individual display equipment can be
System communication.In some embodiments, communication can occur via connection.The connection can be rigid line connection or be wirelessly connected.System
Direct communication can occur between system and display equipment.For example, can occur bluetooth, infrared communication, radio, WiFi or other directly
Communication.In other cases, indirect communication can occur between system and display equipment.For example, network (such as local area network can be passed through
(LAN)) or wide area network (WAN) such as internet) communicate.In some embodiments, using telecommunication network (for example, honeycomb
Telephone network, data network).In some instances, it is communicated using 3G, 4G or 5G network.One can be used in the communications
A or multiple intermediate systems, such as relay system (for example, tower) or router.Alternatively, not using intermediate system.
System can have input module, which receives amplification and be present in from the nucleic acid samples that subject obtains
The user of target nucleic acid (for example, target RNA, target DNA) requests.Any suitable mould that can receive such user's request can be used
Block.The input module may include, for example, the device comprising one or more processors.The input module is built-in in system.
The input module can be integrated into the shell or pedestal of system and/or can enter from hull outside.
Alternatively, the input module can be individually or can separate with system.The input module can pass through connection
(those of description connection elsewhere in such as present disclosure) and system communication.The non-limiting reality of system comprising processor
Example include: desktop computer, laptop computer, tablet computer (for example, iPad、
Galaxy Tab), cellular phone, smart phone (for example, iPhone、The phone of support), it is personal
Digital assistants (PDA), video game console, TV, music playing system (for example,IPod), video playing system
System, pager and calculator.Processor can be with other lists of one or more controllers, computing unit and/or computer system
Member is associated, or is implanted into firmware when needed.If implemented in software, routine (or program) can be stored in any meter
In calculation machine readable memory such as RAM, ROM, flash memory, disk, laser disk or other storage mediums.Similarly, the software
It can be transported to system via any of transfer approach, this method includes, for example, through communication channel, such as telephone wire, Yin Te
Net, local Intranet, wireless connection etc., or via portable medium, such as computer readable disk, flash disc drives.Respectively
A step can be used as various district's groups, operation, tool, module or technology to implement, the latter again can hardware, firmware, software or
Implement in any combination thereof.When implementing within hardware, some or all of these district's groups, operation, technology etc. can be for example
Customize integrated circuit (IC), specific integrated circuit (ASIC), Field Programmable Logic Array (FPGA), programmable logic array
(PLA) etc. implement in.
In some embodiments, the input module, which is configured as receiving, carries out target nucleic acid amplification in amplification module
User's request.The amplification module may include for completing one or more heating and cooling cycle and/or one or more primers
The component of extension.The input module can be directly (for example, by input system, such as by the keyboard of user's operation, mouse
Or touch screen) or indirectly (for example, by wired or wireless connection, including via internet) receive user's request.Input mould
Block can provide the request of user to amplification module via output electronic device.In some embodiments, input module may include
User interface (UI), such as graphic user interface (GUI), which is configured to that user is made to provide amplification target nucleic acid
Request.GUI may include text, figure and/or audio frequency component.GUI can be provided on an electronic display, which includes
The display of system containing computer processor.Such display may include resistance-type or capacitive touch screen.
In some embodiments, the output module includes as being with processor for described in input module
System.The output module may include input equipment as described herein, and/or may include defeated for communicating with amplification module
Enter electronic device.In some embodiments, which is electronic console, as on nucleic acid amplification system display or
Individually display equipment.In some embodiments, which includes UI.In some embodiments, the output mould
Block is operably coupled to the communication interface of computer network such as internet.In some embodiments, which makes
Information is transmitted with any suitable telecommunication media (including computer network, wireless network, cloud, local Intranet or internet)
To the recipient for being in Local or Remote position.In some embodiments, which can analyze connects from amplification module
The data received.The output module can analyze information while expanding and occurring in real time.Post analysis one can be completed in amplification
A little data.In some cases, which includes the report generation that can be generated report and report is sent to recipient
Device, this report may include the amount as described elsewhere herein about amplified production and/or existing any information.Some
In embodiment, which may be in response to automatically transmit information from the information that amplification module receives, such as with original
Data or by include expand module in software carry out data analysis form.Alternatively, the output module can be used receiving
Information is transmitted after the instruction of family.It can electronically be checked by the information that output module transmits or be printed by printer
Come.
Input module, amplification one of module and output module or it is a variety of may include that in the same system, or can wrap
Containing one or more identical components.For example, amplification module also may include that input module, output module or both all include.?
In other examples, the system comprising processor both may include that can also reside in output module in input module.User can make
It is requested to expand target nucleic acid with the system, and the system also can be used and be sent to the information about amplified production
Recipient.In some cases, the system comprising processor is comprised in all three module, so that should include processor
It includes the component expanded in module or any other module that system, which can also be used for control, provides instruction to the component, and receive
The information returned from the instrument.
Figure 1A and Figure 1B provides the example of the system of present disclosure.System 100 may include the pedestal 107 of bottom.?
In pedestal 107, there may be excitation energy source (for example, light sources) 106 guiding energy to including in reaction vessel 104
Sample, to generate from the signal for being present in any amplified production in reaction vessel 104.Pedestal 107 also may include power supply (example
Such as, battery) and/or detector.The system also may include be located at pedestal 107 on and the heating part with 104 thermal communication of reaction vessel
Part (for example, heat block) 105.It can be by including that the power supply in pedestal 107 is powered to heating element 105.The system can also wrap
Containing the shell 102 being releasably attached on pedestal 107.Shell 102 can encapsulate reaction vessel when being installed on pedestal 107
104.Shell 102 may include at least one outlet 103, the outlet 103 allow convective fluid from the source of convective fluid (for example, by
Such as fan of fluid flow components 101 generates) flow through at least one outlet 103 of the arrival of reaction vessel 104.Shell 102 also may include
It can be used as the touch point 108 of switch.For example, touch point 108 and pedestal can be made when shell 102 to be installed on pedestal 107
107 contacts, to power on.Then, power supply will start heating element 105 (for example, passing through controller), be included in improving
With the temperature of the reaction mixture in the reaction vessel 104 of 105 thermal communication of heating element.When the temperature in reaction vessel 104 reaches
When to the first temperature levels, heating (for example, by deactivating heating element 105) can be stopped, and can star fluid flowing
Component 101 is to generate the flowing of convective fluid, so that the convective fluid from its source stream crosses reaction vessel 104 and reaches at least one and
Mouth 103, to reduce the temperature in reaction vessel 104.It, can when the temperature in reaction vessel 104 reaches second temperature level
To deactivate fluid flow components 101, and a heating-cooling circulation can be completed.The circulation can be repeated as many times as desired.
Fig. 2 provides the example of the system of present disclosure.Show the external appearance of system 200.System 200 may include
Pedestal 202 and the shell 205 being installed on pedestal 202.Shell 205 may include at least one outlet 203,204 and of switch button
Display screen 201.When needed, switch button 204 and/or display screen 201 can include by pedestal 202.
Fig. 3 shows the internal structure of the system 300 of present disclosure.System 300 may include pedestal 305.Fluid flowing
Component 301 may be mounted on pedestal 305, and heating element 303 can be installed in parallel pedestal with fluid flow components 301
On 305.Sample holder 302 can be kept by the support member 307 being mounted on pedestal 305 near heating element 303, so that
Sample holder 302 and any reaction vessel fixed by the sample holder will be with 303 thermal communications of heating element.The system can
The controller for being operably coupled to heating element 303 and/or fluid flow components 301 is further included (for example, printed circuit
Plate) 304.Controller 304 can by comprising in systems and be operably coupled to controller 304 switch 306 start and/or stop
With.
Fig. 4 provides the bottom view of the internal structure of the system 400 of present disclosure.The system may include front cover 401, preceding
Lid 401 may include aperture array 402 to allow fluid (for example, air stream) to flow in and out the system.The system can be further
Comprising power supply 403 (for example, battery), to power to heating element 404 and/or fluid flow components 405.
It may include the display 501 in the system of present disclosure that Fig. 5 A, which is illustrated,.Fig. 5 B to Fig. 5 D is provided can be
The example at the interface shown on display 501.Fig. 5 B show can displays temperature (for example, comprising reaction in the reaction vessel
The real time temperature of mixture) mode example.Fig. 5 C and Fig. 5 D, which are shown, can show that negative (Fig. 5 C) or positive (Fig. 5 D) expands
Increase the example of the mode of result.
Fig. 6 provides the example of the reaction vessel 600 of present disclosure.Reaction vessel 600 may include cap 605 and main body
606.Main body 606 may include reaction chamber 604 and the sampler chamber 603 with the fluid communication of reaction chamber 604.Sampler chamber 603 may include out
Mouth 602, and when cap closure, the collecting part 601 for including by cap 605 can be fitted in opening 602.
Fig. 7 shows the viewgraph of cross-section of the reaction vessel 700 of present disclosure.Reaction vessel 700 may include reaction chamber
705 and sampler chamber 703, the sealing element 704 for being partially or wholly separated reaction vessel 705 and sampling container 703 may be present.It can deposit
Sealing sampler chamber opening and prevent wherein content to be externally exposed the seal member 702 of environment.Reaction vessel 700 may be used also
Comprising the cap with collecting part 701, collecting part 701 can be fitted in the opening of sampler chamber and penetrate seal member 702.
Fig. 8 shows the bottom view of the reaction vessel of present disclosure.The reaction vessel may include main body and cap 801, and
And the main body may include reaction chamber 803 and sampler chamber 802.The bottom side 804 of the reaction vessel can be thickness no more than about 0.3mm
Layer.
Computer control system
This disclosure provides the computer control systems for the method for being programmed to realize present disclosure.Fig. 9 is shown
Computer system 901, is programmed or is otherwise configured for sample treatment and analysis, such as droplet generate with
And nucleic acid amplification and detection.The various aspects of the method and system of present disclosure are adjusted in computer system 901.
Computer system 901 includes central processing unit (CPU, also referred herein as " processor " and " computer disposal
Device ") 905, it can be single or multiple core processor, or multiple processors for parallel processing.Computer system 901 is also
Including memory or storage location 910 (for example, random access memory, read-only memory, flash memory), Electronic saving list
First 915 (for example, hard disks), the communication interface 920 (for example, network adapter) for being communicated with one or more other systems with
And peripheral equipment 925, such as cache memory, other memories, data storage and/or electronical display adapter.Storage
Device 910, storage unit 915, interface 920 and peripheral equipment 925 pass through communication bus (solid line) and 905 phases of CPU such as mainboard
Communication.Storage unit 915 can be data storage cell (or data repository) for storing data.Computer system 901 can
Computer network (" network ") 930 is operably coupled to by means of communication interface 920.Network 930 can be internet, internet
And/or extranet, or the Intranet and/or extranet that are communicated with internet.In some cases, network 930 be telecommunications and/
Or data network.Network 930 may include one or more computer servers, which can support distributed meter
It calculates, such as cloud computing.In some cases, network 930 can realize peer-to-peer network by means of computer system 901, this can make with
The equipment that computer system 901 couples can play the role of client or server.
A series of machine readable instructions can be performed in CPU 905, which may be embodied in program or software.
The instruction is storable in the storage locations such as memory 910.The instruction can be directed to CPU 905, and CPU 905 is then programmable
Or otherwise configure method of the CPU 905 to realize present disclosure.Example by the operation executed of CPU 905 may include
Extraction, decoding, execution and write-back.
CPU 905 can be a part of the circuits such as integrated circuit.One or more other assemblies of system 901 can
Including in circuit.In some cases, which is specific integrated circuit (ASIC).
Storage unit 915 can storage file, such as program of driver, library and preservation.Storage unit 915 can store use
User data, for example, user preference and user program.In some cases, computer system 901 may include one or more additional
Data storage cell, the additional-data storage unit are located at outside computer system 901, such as positioned at by Intranet or because of spy
On the remote server that net and computer system 901 communicate.
Computer system 901 can be communicated by network 930 and one or more remote computer systems.For example, calculating
Machine system 901 can be communicated with the remote computer system of user.The example of remote computer system includes personal computer (example
Such as, portable PC), plate or plate PC (for example, iPad、Galaxy Tab), phone,
Smart phone (for example,IPhone, support Android equipment,) or individual digital help
Reason.User can access computer system 901 via network 930.
Method can be realized by way of machine (for example, computer processor) executable code as described herein,
The machine executable code is stored on the Electronic saving position of computer system 901, such as in memory 910 or Electronic saving
On unit 915.Machine executable code or machine readable code can provide in the form of software.In use, the generation
Code can be executed by processor 905.In some cases, the code can be retrieved from storage unit 915 and is stored in memory
In case being obtained by processor 905 on 910.In some cases, electronic memory module 915 can be excluded, and machine can be performed and refer to
Order is stored on memory 910.
The code can by precompile and be configured to have be adapted for carrying out the code processor machine together with make
With, or can be compiled during operation.The code can be provided with programming language, and programming language may be selected so that the code can
It is executed in a manner of precompile or Just-In-Time (as-compiled).
On the other hand, this disclosure provides the non-transitory computer readable mediums comprising machine executable code
Matter, the machine executable code are realized when being executed by one or more computer processors for carrying out chemistry to nucleic acid samples
Or the method for biological respinse.This method may include activation system, which includes the pedestal that (i) includes heating element, wherein should
The occupied area of pedestal is less than or equal to about 5000mm2, (ii) includes the reaction vessel of reaction chamber, the wherein reaction chamber and heating
Component is adjacent and in thermal communication.The reaction chamber may include reaction mixture, which includes nucleic acid samples and nucleic acid
Reagent necessary to expanding.The system can further comprise the shell that (iii) is releasably attached on pedestal.The shell can wrap
Reaction vessel is sealed, and the shell may include at least one outlet, which allows source stream mistake of the convective fluid from convective fluid
Reaction chamber reaches at least one described outlet.The system may include that (iv) makes convective fluid cross reaction chamber from the source stream of convective fluid
Reach the fluid flow components of at least one outlet.This method can further comprise guiding heating element to anti-by (i)
Room is answered to provide thermal energy, and (ii) guidance fluid flow components so that convective fluid crosses reaction chamber arrival from the source stream of convective fluid
At least one described outlet, makes reaction mixture be subjected to one or more heating and cooling cycle, to promote to reaction mixture
Nucleic acid amplification reaction.
On the other hand, this disclosure provides the non-transitory computer readable mediums comprising machine executable code
Matter, the machine executable code realize the side for nucleic acid samples amplification when being executed by one or more computer processors
Method.This method may include activation system, which includes the pedestal that (i) includes heating element, and the occupied area of the pedestal can be small
In or equal to about 5000mm2, (ii) includes the reaction vessel of reaction chamber, which can be adjacent with heating element and heat connects therewith
It is logical, and the reaction chamber may include reaction mixture, and which includes examination necessary to nucleic acid samples and nucleic acid amplification
Agent, and (iii) are releasably attached to the shell on pedestal, which can encapsulate reaction vessel, and the shell may include
Cooling-part, the cooling-part when the shell is installed on pedestal with reaction vessel thermal communication.This method can further comprise
Reaction mixture is set to be subjected to one or more heating and cooling cycle, to promote the nucleic acid amplification reaction to the reaction mixture,
This can adjust the rate of heat addition of reaction vessel using heating element by (i) and (ii) uses cooling-part adjusting reaction vessel
Cooling rate realize.
The various aspects of system and method provided herein, such as computer system 901, may be embodied in programming.This technology
Many aspects be considered " product " or " product ", generally on a type of machine readable media carry or
Machine (or processor) executable code of embodiment and/or the form of associated data.Machine executable code is storable in such as
On the electronic memory modules such as memory (for example, read-only memory, random access memory, flash memory) or hard disk.It " deposits
Storage " type medium may include any or all of tangible memory of computer, processor etc. or its relating module, such as various half
Conductor memory, tape drive, disc driver etc. can provide non-transitory storage at any time for software programming.
The all or part of the software can be communicated sometimes by internet or various other telecommunication networks.Such communication, example
Such as, it can enable software to be loaded into another computer or processor from a computer or processor, for example, from management service
Device or host are loaded into the computer platform of application server.Therefore, the another type of medium packet of software elements can be carried
Include light wave, electric wave and electromagnetic wave, such as across between local device physical interface, pass through wired and optics land line network and logical
It crosses various airlinks and uses.The physical component of this kind of wave, wired or wireless link, optical link etc. are carried,
It is considered the medium of carrying software.As used herein, except tangible " storage " medium of non-transitory is not limited to, otherwise
The terms such as computer or machine " readable medium ", which refer to, participates in providing instruction to processor for any medium of execution.
Therefore, machine readable media, such as computer-executable code can take many forms, including but not limited to: having
Shape storage medium, carrier media or physical transmission medium.Non-volatile memory medium includes such as CD or disk, such as any
Any storage equipment in computer etc., such as can be used for realizing database etc. as shown in the drawings.Volatile storage medium
Including dynamic memory, the main memory of such as such computer platform.Tangible transmission media includes coaxial cable;Copper wire and
Optical fiber, including conducting wire, the conducting wire include the bus in computer system.Carrier wave transmission media can take electric signal or electromagnetic signal
Or the form of sound wave or light wave, such as in radio frequency (RF) and infrared (IR) data communication process generate those of electric signal or
Electromagnetic signal or sound wave or light wave.Therefore, the common form of computer-readable medium includes, for example: floppy disk, flexible disk
(flexible disk), hard disk, tape, any other magnetic medium, CD-ROM, DVD or DVD-ROM, any other optics are situated between
Matter, card punch paper tape, any other physical storage medium, RAM, ROM, PROM and EPROM, FLASH- with hole patterns
The cable or link of carrier wave as EPROM, any other storage chip or cassette, transmission data or the carrier wave of instruction, transmission
(link) or computer can therefrom read any other media of programming code and/or data.These computer-readable medium shapes
Many in formula, which may participate in, is carried to processor for one or more sequences of one or more instruction for executing.
Computer system 901 may include electronic console 935 or communicate that electronic console 935 includes at any time
Between the user interface (UI) 940 of such as nucleic acid sequence information is provided.The example of UI includes but is not limited to graphic user interface (GUI)
With network-based user interface.
The method and system of present disclosure can be realized by one or more algorithms.Algorithm can be by central processing list
Member 905 passes through software realization when executing.Algorithm can such as regulator control system or realization method provided herein.
The devices, systems, and methods of present disclosure can be with other devices, system or method, such as PCT/CN14/
Those devices, system or method described in 094914 and PCT/CN14/078022 are combined, and each of these applications is all
It is incorporated herein by reference in their entirety.
Although the preferred embodiments of the invention have been shown and described herein, those skilled in the art are come
It says it is evident that these embodiments only provide in an illustrative manner.It is not intended to the specific example by providing in specification
To limit the present invention.Although describing the present invention by reference to aforementioned specification, the description of this paper embodiment and diagram are not
It should be explained with restrictive meaning.Those skilled in the art are without departing from the present invention now it will be appreciated that a variety of changes
Change, change and replaces.In addition, it should be understood that all aspects of the invention be not limited to it is set forth herein it is specific describe, configuration or
Relative scale, but depend on a variety of conditions and variable.It should be appreciated that the various of embodiment of the present invention described herein are replaced
It can be used for implementing the present invention for scheme.It is therefore contemplated that the present invention should also cover any such substitution, modification, variation
Or equivalent.Following following claims is intended to limit the scope of the invention, thus the method being included in the scope of these claims and
Structure and its equivalent.
Claims (119)
1. a kind of system for nucleic acid amplification comprising:
Pedestal comprising heating element, wherein the occupied area of the pedestal is less than or equal to about 5000mm2;
Reaction vessel comprising reaction chamber, wherein the reaction chamber is adjacent with the heating element and connects with the heating element heat
It is logical, wherein during use, reaction mixture of the heating element into the reaction chamber provides thermal energy, the reaction mixing
Object includes reagent necessary to nucleic acid samples and nucleic acid amplification;
The shell being releasably attached on the pedestal, wherein the shell encapsulated when being installed on the pedestal it is described anti-
Container is answered, and wherein the shell includes at least one outlet, the outlet allows convective fluid from the convective fluid
The excessively described reaction chamber of source stream reaches at least one described outlet;
Fluid flow components make described in the convective fluid reaches from the excessively described reaction chamber of the source stream of the convective fluid
At least one outlet;And
It is operably coupled to the controller of the heating element and the fluid flow components, wherein the controller is programmed
To guide the heating element to provide thermal energy to the reaction chamber by (i), and (ii) guidance fluid flow components so that
The excessively described reaction chamber of the source stream for obtaining the convective fluid from the convective fluid reaches at least one described outlet, makes described
Reaction mixture is subjected to one or more heating and cooling cycle, to promote the nucleic acid amplification reaction to the reaction mixture.
2. system according to claim 1, wherein the occupied area of the reaction chamber is less than or equal to about 1000mm2。
3. system according to claim 2, wherein the occupied area is less than or equal to about 500mm2。
4. system according to claim 3, wherein the occupied area is less than or equal to about 300mm2。
5. system according to claim 1, wherein the occupied area of the pedestal is less than or equal to about 2000mm2。
6. system according to claim 1, wherein the occupied area for the shell being installed on the pedestal be less than or
Equal to about 5000mm2。
7. system according to claim 1, wherein the cross section of the reaction chamber is less than the cross section of the heating element.
8. system according to claim 1, wherein the ratio between the surface area of the reaction chamber and volume are at least 100mm-1。
9. system according to claim 1 further comprises the power supply powered to the heating element.
10. system according to claim 9, wherein the power supply is powered to the fluid flow components.
11. system according to claim 9 further comprises being operably coupled to institute in the pedestal or the shell
The switch of power supply is stated, wherein the switch-mode regulation is from the power supply to the power supply of the heating element.
12. system according to claim 11, wherein when the shell is installed on the pedestal, the switch guidance
From the power supply to the power supply of the heating element.
13. system according to claim 1, wherein the shell includes room, the room is when being installed on the pedestal
Encapsulate the reaction vessel.
14. system according to claim 1 further comprises the sample holder being installed on the heating element, institute
Sample holder is stated to receive and fix the reaction vessel.
15. system according to claim 14, wherein when the reaction vessel is fixed on the sample holder, institute
It is adjacent and in thermal communication with the heating element to state reaction chamber.
16. system according to claim 1, wherein the pedestal, which further includes, is operably coupled to the reaction appearance
The excitation energy source of device indicates the core wherein the excitation energy source provides excitation energy to the reaction vessel with induction
The present or absent signal of the amplified production of sour amplified reaction.
17. system according to claim 16 further comprises the first sensor with the reaction vessel sensing communication,
Wherein the first sensor detection indicates the present or absent signal of the amplified production.
18. system according to claim 17, wherein the first sensor is optical sensor, and the wherein letter
It number is optical signalling.
19. according to claim 1 or system described in 17, further comprising the second sensing with the reaction vessel sensing communication
Device, wherein the second sensor detects the temperature of the indoor one or more positions of the reaction of the reaction vessel.
20. system according to claim 17 further comprises being operably coupled in the pedestal or the shell
The display of the first sensor, wherein the display be configured as display indicate the amplified production the presence or
The signal being not present.
21. system according to claim 19 further comprises being operably coupled in the pedestal or the shell
The display of the first sensor and/or the second sensor, wherein the display is configured as:
1) display indicates the present or absent signal of the amplified production, and/or
2) temperature at the indoor one or more of positions of the reaction of the reaction vessel is shown.
22. system according to claim 16, wherein the excitation energy source is light source.
23. system according to claim 1, wherein the convective fluid is convection gas.
24. system according to claim 23, wherein the convection gas is air.
25. system according to claim 1, wherein the fluid flow components are fans.
26. system according to claim 1, wherein the fluid flow components are installed to the shell or the pedestal
On.
27. system according to claim 1, wherein the source of the convective fluid is refrigeration unit.
28. system according to claim 1, wherein the heating element includes infrared heating unit.
29. system according to claim 1, wherein the heating element includes peltier heating unit.
30. system according to claim 1, wherein the heating element includes heating unit containing aluminium.
31. system according to claim 1, wherein the heating element includes electrical resistor heating element.
32. system according to claim 1, wherein the controller is programmed to guide the heating element to described anti-
It answers room to provide thermal energy until the reaction mixture reaches the first temperature, and guides the fluid flow components so that described right
Stream fluid flows through the reaction chamber until the reaction mixture reaches the second temperature lower than first temperature.
33. system according to claim 32, wherein the controller is programmed to reach institute when the reaction mixture
The fluid flow components are guided when stating second temperature to reduce or terminate the flowing of the convective fluid.
34. system according to claim 1, wherein the controller is included in the pedestal.
35. system according to claim 1, wherein the reaction mixture includes one or more primers and polymerase.
36. system according to claim 35, wherein the reaction mixture includes buffer.
37. system according to claim 35, wherein the reaction mixture includes the active of the adjusting polymerase
Cation.
38. the system according to claim 37, wherein the cation includes Mg2+Or Mn2+。
39. system according to claim 35, wherein one or more primers have for HBV, HCV, FluA,
FluB, CA16, EV71, enterovirus, EBOV, EBV, measles virus, salmonella, HPV and/or the nucleic acid sequence of HIV selection.
40. system according to claim 1, wherein the nucleic acid amplification reaction is polymerase chain reaction (PCR).
41. system according to claim 1, wherein the mean temperature of the convective fluid is below about 15 DEG C.
42. system according to claim 41, wherein the mean temperature of the convective fluid is below about 10 DEG C.
43. system according to claim 1, wherein the controller as the heating element by using described in being provided
Thermal energy is come to control the rate of heat addition of the reaction chamber, and using the flowing that the convective fluid flows through the reaction chamber
The cooling rate of the reaction chamber is controlled, to heat and/or cool to reaction mixture offer.
44. system according to claim 43, wherein when the rate of heat addition is greater than the cooling rate, the reaction
Mixture is subjected to heating.
45. system according to claim 43, wherein when the rate of heat addition is less than the cooling rate, the reaction
Mixture is subjected to cool to.
46. system according to claim 43, wherein the rate of heat addition is at least 5 DEG C/s.
47. system according to claim 43, wherein the cooling rate is at least 5 DEG C/s.
48. system according to claim 1, wherein the controller is not in the case where the switch is not opened
The reaction mixture is set to be subjected to one or more of heating and cooling cycle.
49. system according to claim 1, wherein after the switch is opened after postponing after a period of time, institute
Stating controller makes the reaction mixture be subjected to one or more of heating and cooling cycle.
50. system according to claim 1, wherein the reaction vessel further includes sampling unit, and wherein institute
Stating sampling unit includes the sampler chamber being in fluid communication with the reaction chamber.
51. system according to claim 50, wherein the sampling unit further includes the collection for collecting nucleic acid samples
Component.
52. system according to claim 51, wherein the sampling unit, which further includes, seals opening for the sampler chamber
The seal member of mouth.
53. system according to claim 52, wherein during use, the collecting part pierce through the seal member with
The nucleic acid samples are discharged into the sampler chamber.
54. system according to claim 1, wherein the thickness of the side of the reaction chamber adjacent with the heating element
Less than about 1mm.
55. a kind of method for nucleic acid amplification comprising:
(a) system is activated, the system comprises the pedestals that (i) includes heating element, wherein the occupied area of the pedestal is small
In or equal to about 5000mm2, (ii) includes the reaction vessel of reaction chamber, wherein the reaction chamber is adjacent with the heating element simultaneously
With the heating element thermal communication, wherein the reaction chamber includes reaction mixture, the reaction mixture includes nucleic acid samples
With reagent necessary to nucleic acid amplification, (iii) is releasably attached to the shell on the pedestal, wherein shell encapsulated institute
Reaction vessel is stated, wherein the shell includes at least one outlet, the outlet allows convective fluid from the convective fluid
The source stream reaction chamber excessively reaches at least one described outlet, and (iv) fluid flow components, make the convective fluid from
The excessively described reaction chamber of the source stream of the convective fluid reaches at least one described outlet;And
(b) heating element is guided to provide thermal energy to the reaction chamber by (i), and (ii) guides the fluid flow components
So that the excessively described reaction chamber of the source stream of the convective fluid from the convective fluid reaches at least one described outlet, make
The reaction mixture is subjected to one or more heating and cooling cycle, anti-to the nucleic acid amplification of the reaction mixture to promote
It answers.
56. method according to claim 55, wherein the occupied area of the reaction chamber is less than or equal to about 1000mm2。
57. method according to claim 55, wherein the occupied area of the pedestal is less than or equal to about 2000mm2。
58. method according to claim 55, wherein the occupied area for the shell being installed on the pedestal is less than
Or it is equal to about 5000mm2。
59. method according to claim 55, wherein the cross section of the reaction chamber is less than the transversal of the heating element
Face.
60. method according to claim 55, wherein the ratio between the surface area of the reaction chamber and volume are at least 100mm-1。
61. method according to claim 55, wherein the activation in (a) be by with power supply to the heating element
Power supply and carry out.
62. method according to claim 61, wherein the power supply is powered to the fluid flow components.
63. method according to claim 61, wherein being operably connected by opening in the pedestal or the shell
The electric power is supplied to the switch of the power supply.
64. method according to claim 63, wherein by the shell is installed on the pedestal open it is described
Switch.
65. method according to claim 55, wherein the shell includes room, the room is when being installed on the pedestal
Encapsulate the reaction vessel.
66. method according to claim 55 further comprises that the reaction vessel is fixed to installation before (a)
On sample holder on to the heating element.
67. method according to claim 66, wherein when the reaction vessel is fixed on the sample holder, institute
It is adjacent and in thermal communication with the heating element to state reaction chamber.
68. method according to claim 55 is further comprised providing excitation energy to the reaction vessel, is referred to induction
Show the present or absent signal of the amplified production of the nucleic acid amplification reaction.
69. method according to claim 68 further comprises providing to pass with the first of the reaction vessel sensing communication
Sensor, to detect the present or absent signal for indicating the amplified production.
70. method according to claim 69, wherein the first sensor is optical sensor, and the wherein letter
It number is optical signalling.
71. method according to claim 69 further comprises providing to pass with the second of the reaction vessel sensing communication
Sensor, to detect the temperature of the indoor one or more positions of the reaction of the reaction vessel.
It further comprise that operationally coupling is provided in the pedestal or the shell 72. method according to claim 71
It is bonded to the display of the first sensor and/or the second sensor, wherein the display is configured as: (1) showing
Indicate that the present or absent signal of the amplified production, and/or (2) show the described anti-of the reaction vessel
Answer the temperature at indoor one or more of positions.
It further comprise that operationally coupling is provided in the pedestal or the shell 73. method according to claim 69
It is bonded to the display of the first sensor, wherein the display, which is configured as display, indicates that the described of the amplified production is deposited
Or the signal that is not present.
74. method according to claim 68, wherein the excitation energy source is light source.
75. method according to claim 55, wherein the convective fluid is convection gas.
76. the method according to claim 75, wherein the convection gas is air.
77. method according to claim 55, wherein the fluid flow components are fans.
78. method according to claim 55, wherein the fluid flow components are installed to the shell or the base
On seat.
79. method according to claim 55, wherein the source of the convective fluid is refrigeration unit.
80. method according to claim 55 further comprises that will be equipped with the institute of the shell thereon before (a)
Pedestal is stated to be placed in refrigeration unit.
81. method according to claim 55, wherein the heating element includes infrared heating unit.
82. method according to claim 55, wherein the heating element includes peltier heating unit.
83. method according to claim 55, wherein the heating element includes heating unit containing aluminium.
84. method according to claim 55, wherein the heating element includes electrical resistor heating element.
85. method according to claim 55, wherein thermal energy is provided to the reaction chamber, until the reaction mixture reaches
To the first temperature, and the convective fluid is wherein made to flow through the reaction chamber, until the reaction mixture reaches lower than institute
State the second temperature of the first temperature.
86. the method according to claim 85, further comprise when the reaction mixture reaches the second temperature,
Reduce or terminate the flowing of the convective fluid.
87. method according to claim 55, wherein the reaction mixture includes one or more primers and polymerase.
88. the method according to claim 87, wherein the reaction mixture includes buffer.
89. the method according to claim 87, wherein the reaction mixture includes the active of the adjusting polymerase
Cation.
90. the method according to claim 89, wherein the cation includes Mg2+Or Mn2+。
91. the method according to claim 87, wherein one or more primers have for HBV, HCV, FluA,
FluB, CA16, EV71, enterovirus, EBOV, EBV, measles virus, salmonella, HPV and/or the nucleic acid sequence of HIV selection.
92. method according to claim 55, wherein the nucleic acid amplification reaction is polymerase chain reaction (PCR).
93. method according to claim 55, further comprise using the thermal energy provided by the heating element Lai
The rate of heat addition of the reaction chamber is controlled, and flows through the flowing of the reaction chamber using the convective fluid to control
State the cooling rate of reaction chamber.
94. the method according to claim 93, wherein the rate of heat addition is greater than the cooling rate, to make described anti-
Mixture is answered to be subjected to heating.
95. the method according to claim 93, wherein the rate of heat addition is less than the cooling rate, to make described anti-
Mixture is answered to be subjected to cool to.
96. the method according to claim 93, wherein the rate of heat addition is at least 5 DEG C/s.
97. the method according to claim 93, wherein the cooling rate is at least 5 DEG C/s.
98. method according to claim 55, wherein in the case where the switch is not opened, not making in (b)
The reaction mixture is subjected to one or more of heating and cooling cycle.
99. method according to claim 55, wherein being prolonged after a period of time after the switch is opened in (b)
After late, the reaction mixture is made to be subjected to one or more of heating and cooling cycle.
100. method according to claim 55 further comprises deactivating the system after (b).
101. method according to claim 55 further comprises being placed on the nucleic acid samples described before (a)
In reaction vessel.
102. method described in 01 according to claim 1, wherein the reaction vessel further includes sampling unit, and wherein
The sampling unit include collecting part and with the reaction chamber be in fluid communication sampler chamber, wherein by on it or its
In have collected the collecting parts of the nucleic acid samples and pierce through the seal member for sealing the opening of the sampler chamber, by the core
Sour sample is placed in the reaction vessel.
103. a kind of system for nucleic acid amplification comprising:
Pedestal comprising heating element, wherein the occupied area of the pedestal is less than or equal to about 5000mm2;
Reaction vessel comprising reaction chamber, wherein the reaction chamber is adjacent and in thermal communication with the heating element, wherein
During use, reaction mixture of the heating element into the reaction chamber provides thermal energy, and the reaction mixture includes core
Reagent necessary to sour sample and nucleic acid amplification;
The shell being releasably attached on the pedestal, wherein the shell encapsulated when being installed on the pedestal it is described anti-
Container is answered, and wherein the shell includes cooling-part, the cooling-part is when the shell is installed on the pedestal
With the reaction vessel thermal communication;
It is operably coupled to the controller of the heating element, wherein the controller is programmed to by described in (i) use
Heating element adjusts the rate of heat addition of the reaction vessel, and (ii) adjusts the cold of the reaction vessel using the cooling-part
But rate makes the reaction mixture be subjected to one or more heating and cooling cycle, to promote to the reaction mixture
Nucleic acid amplification reaction.
104. system described in 03 according to claim 1, wherein the cooling-part is at least about 0.2J/g*K's by thermal capacity
Material is formed.
105. system described in 04 according to claim 1, wherein the cooling-part is at least about 0.3J/g*K's by thermal capacity
Material is formed.
106. system described in 05 according to claim 1, wherein the cooling-part is at least about 0.4J/g*K's by thermal capacity
Material is formed.
107. system described in 06 according to claim 1, wherein the cooling-part is at least about 0.5J/g*K's by thermal capacity
Material is formed.
108. system described in 07 according to claim 1, wherein the cooling-part is at least about 1.0J/g*K's by thermal capacity
Material is formed.
109. system described in 03 according to claim 1, wherein the cooling-part is the solid comprising copper.
110. a kind of method for nucleic acid amplification comprising:
(a) system is activated, the system comprises the pedestals that (i) includes heating element, wherein the occupied area of the pedestal is small
In or equal to about 5000mm2, (ii) includes the reaction vessel of reaction chamber, wherein the reaction chamber is adjacent with the heating element simultaneously
In thermal communication, wherein the reaction chamber includes reaction mixture, the reaction mixture includes nucleic acid samples and nucleic acid amplification
Necessary reagent, and (iii) are releasably attached to the shell on the pedestal, wherein reacting described in the shell encapsulated
Container, wherein the shell includes cooling-part, the cooling-part when the shell is installed on the pedestal with it is described
Reaction vessel thermal communication;And
(b) rate of heat addition of the reaction vessel is adjusted using the heating element by (i), and (ii) uses the cooling end
Part adjusts the cooling rate of the reaction vessel, and the reaction mixture is made to be subjected to one or more heating and cooling cycle, with
Promote the nucleic acid amplification reaction to the reaction mixture.
111. method described in 10 according to claim 1, wherein the occupied area of the reaction chamber is less than or equal to about 1000mm2。
112. method described in 10 according to claim 1, wherein the occupied area of the pedestal is less than or equal to about 2000mm2。
113. method described in 10 according to claim 1, wherein the occupied area for the shell being installed on the pedestal is small
In or equal to about 5000mm2。
114. method described in 10 according to claim 1 further comprises providing excitation energy to the reaction vessel, with induction
Indicate the present or absent signal of the amplified production of the nucleic acid amplification reaction.
115. method described in 14 according to claim 1 further comprises first provided with the reaction vessel sensing communication
Sensor, to detect the present or absent signal for indicating the amplified production.
116. method described in 15 according to claim 1, wherein the first sensor is optical sensor, and wherein described
Signal is optical signalling.
117. method described in 15 according to claim 1 further comprises second provided with the reaction vessel sensing communication
Sensor, to detect the temperature of the indoor one or more positions of the reaction of the reaction vessel.
118. method described in 17 according to claim 1 further comprises providing in the pedestal or the shell operationally
It is coupled to the display of the first sensor and/or the second sensor, wherein the display is configured as: (1) showing
Show that the present or absent signal for indicating the amplified production, and/or (2) show the described of the reaction vessel
React the temperature at indoor one or more of positions.
119. method described in 15 according to claim 1 further comprises providing in the pedestal or the shell operationally
It is coupled to the display of the first sensor, wherein the display, which is configured as display, indicates the described of the amplified production
The present or absent signal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2016/087046 WO2017219350A1 (en) | 2016-06-24 | 2016-06-24 | Systems and methods for thermal cycling |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109642197A true CN109642197A (en) | 2019-04-16 |
Family
ID=60783778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201680088726.2A Pending CN109642197A (en) | 2016-06-24 | 2016-06-24 | system and method for thermal cycling |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN109642197A (en) |
WO (1) | WO2017219350A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020072112A1 (en) * | 1990-11-29 | 2002-06-13 | John Girdner Atwood | Thermal cycler for automatic performance of the polymerase chain reaction with close temperature control |
US20060105433A1 (en) * | 2004-11-18 | 2006-05-18 | Bickmore William D Jr | Rapid thermocycler |
CN101522909A (en) * | 2006-05-17 | 2009-09-02 | 加利福尼亚技术学院 | Thermal cycling system |
WO2012166913A1 (en) * | 2011-06-01 | 2012-12-06 | Streck, Inc. | Rapid thermocycler system for rapid amplification of nucleic acids and related methods |
CN103243017A (en) * | 2012-02-09 | 2013-08-14 | 李响 | Thin-type PCR instrument for heat storage and heat radiation by utilization of overall structure |
CN105358673A (en) * | 2014-05-21 | 2016-02-24 | 卡尤迪生物科技(北京)有限公司 | Systems and methods for thermal cycling |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015176253A1 (en) * | 2014-05-21 | 2015-11-26 | Coyote Bioscience Co., Ltd. | Systems and methods for low power thermal cycling |
-
2016
- 2016-06-24 CN CN201680088726.2A patent/CN109642197A/en active Pending
- 2016-06-24 WO PCT/CN2016/087046 patent/WO2017219350A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020072112A1 (en) * | 1990-11-29 | 2002-06-13 | John Girdner Atwood | Thermal cycler for automatic performance of the polymerase chain reaction with close temperature control |
US20060105433A1 (en) * | 2004-11-18 | 2006-05-18 | Bickmore William D Jr | Rapid thermocycler |
CN101522909A (en) * | 2006-05-17 | 2009-09-02 | 加利福尼亚技术学院 | Thermal cycling system |
WO2012166913A1 (en) * | 2011-06-01 | 2012-12-06 | Streck, Inc. | Rapid thermocycler system for rapid amplification of nucleic acids and related methods |
CN103243017A (en) * | 2012-02-09 | 2013-08-14 | 李响 | Thin-type PCR instrument for heat storage and heat radiation by utilization of overall structure |
CN105358673A (en) * | 2014-05-21 | 2016-02-24 | 卡尤迪生物科技(北京)有限公司 | Systems and methods for thermal cycling |
Also Published As
Publication number | Publication date |
---|---|
WO2017219350A1 (en) | 2017-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230265495A1 (en) | Analytic Device | |
CN106520517B (en) | A kind of portable micro-fluidic chip LAMP visual detector and its detection method | |
TW201737135A (en) | Methods and systems for disease monitoring and assessment | |
US20170157613A1 (en) | Systems and methods for thermal cycling | |
ES2809566T3 (en) | Methods and systems for nucleic acid amplification | |
WO2017088834A1 (en) | Methods and systems for nucleic acid amplification | |
CN106459871A (en) | Thermal cycler lid configuration and use thereof | |
Chu et al. | Recent advances and challenges of biosensing in point-of-care molecular diagnosis | |
US20180080063A1 (en) | Apparatus and methods for conducting chemical reactions | |
CN206173319U (en) | Portable micro -fluidic chip LAMP visual detection appearance | |
CN105121663B (en) | Methods and systems for nucleic acid amplification | |
WO2016106717A1 (en) | Apparatus and methods for conducting chemical reactions | |
CN106367336B (en) | Apparatus, method and system for performing chemical reactions | |
CA2960859A1 (en) | Hybrid multi-step nucleic acid amplification | |
CN109642197A (en) | system and method for thermal cycling | |
WO2020146519A1 (en) | Methods and systems for identification of spinal muscular atrophy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: A211, 2f, Zhongguancun Development building, No. 12, Shangdi Information Road, Haidian District, Beijing 100085 Applicant after: Beijing kayudi Biotechnology Co.,Ltd. Address before: A211, 2f, Zhongguancun Development building, No. 12, Shangdi Information Road, Haidian District, Beijing 100085 Applicant before: COYOTE BIOSCIENCE CO.,LTD. |
|
CB02 | Change of applicant information | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190416 |
|
WD01 | Invention patent application deemed withdrawn after publication |